Biological medication for rheuma

RX_RHEUMA_BIOLOGICAL

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — L04AA24\|L04AC03\|L04AB04\|L04AB01\|L04AB06\|L04AB02\|L04AB05\|L04AA26\|L01XC02\|L04AC10\|L04AC07\|L04AC05 1 out of 7 registries used, show all original rules.	6959
4. Check minimum number of events Min. number of events 3	6959
5. Include endpoints None	6959
6. Filter based on genotype QC (FinnGen only)	6959

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	RX_RHEUMA_BIOLOGICAL
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	L04AA24\|L04AC03\|L04AB04\|L04AB01\|L04AB06\|L04AB02\|L04AB05\|L04AA26\|L01XC02\|L04AC10\|L04AC07\|L04AC05
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Biological medication for rheuma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	27308	15324	11931
Only index persons	26669	14962	11707
Unadjusted period prevalence (%)
Whole population	0.39	0.44	0.33
Only index persons	0.50	0.55	0.45
Median age at first event (years)
Whole population	45.20	45.96	44.26
Only index persons	45.68	46.51	44.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6959	4287	2672
Unadjusted period prevalence (%)	1.35	1.46	1.18
Median age at first event (years)	47.84	47.84	47.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5658: Matched controls
56579

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AA17

ATC

[U] adalimumab; parenteral

672.7

323.0

378

L04AB05

ATC

certolizumab pegol; parenteral

+∞

323.0

607

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

84.1

323.0

4516

2545

L04AA01

ATC

[U] ciclosporin; systemic

30.2

323.0

543

198

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

330.1

323.0

890

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

27.7

323.0

470

184

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.5

323.0

3336

13650

M45

ICD-10 Finland

Ankylosing spondylitis

38.3

323.0

1094

352

D05AX52

ATC

calcipotriol, combinations; topical

8.8

323.0

933

1243

M07.3

ICD-10 Finland

Other psoriatic arthropathies

36.4

323.0

508

153

H02AB07

ATC

prednisone; oral

4.8

323.0

1452

3764

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

79.5

323.0

2434

532

L04AB01

ATC

etanercept; parenteral

3687.9

323.0

2396

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

91.2

323.0

4406

2099

L04AA13

ATC

leflunomide; oral

75.2

323.0

1680

316

L04AA11

ATC

[U] etanercept; parenteral

492.8

323.0

456

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.5

323.0

3058

8680

A07EA06

ATC

budesonide; oral, local oral

11.0

323.0

758

784

A07EC01

ATC

sulfasalazine; oral, rectal

55.6

323.0

3611

1736

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1771.8

323.0

4250

P01BA02

ATC

hydroxychloroquine; oral

21.9

323.0

2408

1848

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

173.7

323.0

492

L40.0

ICD-10 Finland

Psoriasis vulgaris

12.1

323.0

927

898

M13.9

ICD-10 Finland

Arthritis, unspecified

8.1

323.0

1132

1701

A07EC02

ATC

mesalazine; oral, rectal

6.9

323.0

914

1539

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

24.0

323.0

878

430

M01CB01

ATC

sodium aurothiomalate; parenteral

52.8

323.0

672

144

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

5.8

323.0

1112

2304

H02AB06

ATC

prednisolone; systemic

10.6

323.0

4647

17135

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

10.0

323.0

1068

1288

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

33.4

323.0

2710

1516

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

33.6

323.0

2670

1465

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

37.7

323.0

2053

841

WZA10

NOMESCO Finland

Long statement of health and health related matters

22.7

323.0

498

240

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1426.6

323.0

4342

127

L04AC07

ATC

tocilizumab; parenteral

3566.4

323.0

346

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

7.1

323.0

1374

2430

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

29.4

323.0

702

271

D05AX02

ATC

calcipotriol; topical

11.3

323.0

703

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

32.3

323.0

951

352

L04AA24

ATC

abatacept; parenteral

+∞

323.0

491

L04AB06

ATC

golimumab; parenteral

3627.7

323.0

1205

L04AX01

ATC

azathioprine; systemic

15.8

323.0

1303

1050

L04AB04

ATC

adalimumab; parenteral

6574.6

323.0

3336

L04AC05

ATC

ustekinumab; parenteral

1143.2

323.0

520

ZX120

NOMESCO Finland

Intravenous

5.8

323.0

1107

2275

L88

ICPC

Rheumatoid/seropositive arthritis

37.5

323.0

1652

615

K50.8

ICD-10 Finland

Other Crohn disease

20.2

323.0

573

314

L40.5

ICD-10 Finland

Arthropathic psoriasis

34.4

323.0

765

256

L04AC10

ATC

secukinumab; parenteral

5930.6

323.0

548

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

25.6

323.0

881

405

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

28.9

322.1

444

166

K50.0

ICD-10 Finland

Crohn disease of small intestine

18.8

321.2

507

294

L04AD01

ATC

ciclosporin; systemic

15.8

304.1

514

356

TNG10

NOMESCO Finland

Puncture of knee

28.3

297.9

413

157

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

27.3

294.4

412

162

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

16.2

288.3

482

324

K50.9

ICD-10 Finland

Crohn disease, unspecified

17.8

288.0

464

283

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

71.9

284.1

326

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

63.8

278.1

325

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

19.4

277.9

433

240

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

8.6

276.2

638

825

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

15.9

273.1

460

314

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

49.6

269.0

328

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

11.7

265.4

512

475

D07XC01

ATC

betamethasone, combinations; topical

4.3

262.3

1123

3108

NH3EA

NOMESCO Finland

Feet X-ray examination with load

13.4

252.9

458

370

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

6.0

251.8

760

1434

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

12.8

243.5

449

377

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

19.2

236.0

369

205

D05BB02

ATC

acitretin; oral

12.3

234.9

442

387

K50.1

ICD-10 Finland

Crohn disease of large intestine

16.7

232.1

382

244

M01AH01

ATC

celecoxib; oral (coxibs)

3.3

230.1

1402

5144

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

33.3

228.2

303

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

13.6

224.9

404

319

L04AA29

ATC

tofacitinib; oral

78.4

217.7

247

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

34.6

215.2

283

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

11.0

214.5

426

415

UJF32

NOMESCO Finland

Coloscopy

2.9

213.9

1678

7262

A02BC02

ATC

pantoprazole; systemic

2.4

211.3

3813

25958

E0000UV

ATC

2.4

210.3

2707

15485

291

Kela drug reimbursment

Tofacitinib

101.4

203.8

224

UJF30

NOMESCO Finland

Ileoscopy through colon

4.1

202.9

891

2475

K51.5

ICD-10 Finland

Left sided colitis

7.7

202.4

497

697

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

26.1

200.0

283

114

XX9XE

NOMESCO Finland

Other ultrasound examination

22.9

199.8

294

135

M01AC06

ATC

meloxicam; systemic, rectal

2.4

199.0

2369

12895

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

30.5

197.7

268

D05AX03

ATC

calcitriol; topical

19.0

194.8

305

169

M01AH05

ATC

etoricoxib; oral

2.3

193.4

3732

25659

M01CB03

ATC

auranofin; oral

35.1

190.2

249

L04AC13

ATC

ixekizumab; parenteral

171.8

190.0

199

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

7.0

187.7

491

754

D07AC01

ATC

betamethasone; topical

2.4

186.0

2206

11868

D07AD01

ATC

clobetasol; topical

3.1

185.6

1210

4569

ZX140

NOMESCO Finland

Intra articular

25.7

183.9

261

106

N02AX02

ATC

tramadol; systemic, rectal

2.3

179.3

2526

14721

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

30.0

175.7

239

NDG30

NOMESCO Finland

Fusion of wrist, total

50.9

174.0

211

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.2

170.9

2751

16932

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

23.3

160.9

235

105

3006

Kela drug reimbursment

Baricitinib

95.1

158.1

175

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

34.4

156.7

206

3005

Kela drug reimbursment

Tofacitinib

47.0

155.3

191

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

15.0

155.3

266

186

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.2

155.1

2242

12956

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.4

154.2

857

2847

L04AA37

ATC

baricitinib; oral

108.2

153.9

168

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

151.9

1350

6091

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.9

151.5

451

817

R4120

NOMESCO Finland

Occupational therapy

4.3

150.9

614

1564

293

Kela drug reimbursment

Baricitinib

95.0

150.0

166

L01BB02

ATC

mercaptopurine; oral

13.3

149.9

270

212

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

14.1

148.8

261

193

M05BA04

ATC

alendronic acid; oral

4.9

148.7

525

1158

NG1DA

NOMESCO Finland

X-ray of knees

10.7

145.1

290

283

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.1

143.9

2819

18376

H20.1

ICD-10 Finland

Chronic iridocyclitis

14.4

140.5

244

176

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

139.7

1653

8596

E000001

ATC

2.4

137.6

1455

7147

NF1AA

NOMESCO Finland

Hip X-ray examination

4.2

137.3

573

1489

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.7

136.7

668

1993

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

62.9

136.0

159

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

9.2

135.9

296

338

WZC30

NOMESCO Finland

Teaching

2.9

129.7

922

3600

R4110

NOMESCO Finland

Physiotherapy

2.2

126.6

1618

8649

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

19.4

126.0

195

104

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.8

125.4

586

1678

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.1

125.2

525

1366

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.5

121.5

380

727

NDL52

NOMESCO Finland

Tenosynovectomy of hand

21.5

121.0

181

M06

ICD-10 Finland

Other rheumatoid arthritis

27.4

120.9

168

4AB02

NOMESCO Finland

31.6

119.5

160

4AA12

NOMESCO Finland

34.1

118.6

156

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.3

118.5

670

2227

J01DB01

ATC

cefalexin; oral

2.2

117.9

4760

39762

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

5.6

117.8

366

694

A07EA02

ATC

hydrocortisone; rectal

6.6

116.3

316

505

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

46.9

115.6

142

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

114.8

2321

14856

M01AE02

ATC

naproxen; oral, rectal

1.9

114.6

3433

25339

M01AH02

ATC

rofecoxib; oral

2.9

114.1

798

3062

UJF92

NOMESCO Finland

Capsular endoscopy

7.2

113.3

288

419

N02BE01

ATC

paracetamol; systemic, rectal

2.2

113.3

4774

40107

A02BC03

ATC

lansoprazole; oral

2.1

111.7

1618

9044

H02AB04

ATC

methylprednisolone; systemic

2.5

108.0

943

4118

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

103.4

613

2098

L04AC14

ATC

sarilumab; systemic

1006.1

101.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.9

101.2

700

2656

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

55.7

100.8

120

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

22.3

100.4

148

L40.8

ICD-10 Finland

Other psoriasis

15.4

100.4

169

113

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

25.1

99.8

142

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

41.2

99.3

125

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

99.3

2251

14782

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

92.6

98.3

109

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

10.8

98.1

194

185

TNH10

NOMESCO Finland

Joint puncture, ankle joint or foot joint

53.3

95.9

115

134

Kela drug reimbursment

General erythroderma

28.1

95.8

132

L40.9

ICD-10 Finland

Psoriasis, unspecified

9.5

95.6

203

221

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

33.6

94.9

125

K51.8

ICD-10 Finland

Other ulcerative colitis

7.6

93.4

228

312

J01FF01

ATC

clindamycin; systemic

2.0

92.4

1607

9526

M25.5

ICD-10 Finland

Pain in joint

1.9

91.8

1749

10718

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

7.3

91.6

230

328

L01CB

ATC

Podophyllotoxin derivatives

60.0

90.2

106

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

18.9

89.9

140

D07AC13

ATC

mometasone; topical

1.9

89.7

1692

10313

J01MA02

ATC

ciprofloxacin; systemic

1.8

88.5

1987

12861

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

6.8

88.5

233

356

S91

ICPC

Psoriasis

13.7

88.3

156

117

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

87.9

1847

11675

WX002

NOMESCO Finland

Sedation and analgesia

2.2

87.4

1085

5581

E000002

ATC

2.4

86.5

818

3692

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

86.4

981

4842

C10AC01

ATC

colestyramine; oral

5.5

86.3

269

510

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

5.9

85.7

251

441

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

4.5

85.6

319

735

L04AA32

ATC

apremilast; oral

35.3

85.4

111

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

10.9

84.8

167

158

RT272

NOMESCO Finland

22.4

83.7

123

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

12.6

83.7

153

124

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

83.6

1628

9983

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

83.3

568

2121

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

6.7

83.2

220

338

M13.0

ICD-10 Finland

Polyarthritis, unspecified

9.6

82.8

174

186

L40

ICD-10 Finland

Psoriasis

7.2

82.0

206

294

7143C

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]

61.0

82.0

M01AX01

ATC

nabumetone; oral

4.1

81.3

338

864

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

26.8

81.1

113

ZX112

NOMESCO Finland

Subcutaneous

6.4

80.4

221

358

A02BC05

ATC

esomeprazole; systemic

1.8

80.3

2158

14676

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

15.2

79.5

134

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

8.8

79.5

176

206

L04AC16

ATC

guselkumab; systemic

82.3

79.2

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

6.9

78.4

203

303

SPAT1202

SPAT

Intra-articular injection

5.4

78.3

248

479

E000003

ATC

3.5

78.0

389

1162

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

28.9

77.0

105

H02AB08

ATC

triamcinolone; systemic

24.3

76.9

110

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

75.3

619

2578

WX320

NOMESCO Finland

Spinalanesthesy

2.0

75.1

1183

6664

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

37.5

74.9

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

15.0

74.3

126

TQW80

NOMESCO Finland

Local dermatologic skincare

5.2

74.0

241

480

ZXA00

NOMESCO Finland

Right side

1.9

73.9

1321

7794

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

36.7

73.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.4

72.7

374

1143

K07.60

ICD-10 Finland

Snapping jaw

3.1

71.9

426

1442

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

15.5

71.8

120

NDF60

NOMESCO Finland

Operation for osteochondritis of a joint of hand,v

34.6

70.6

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

25.8

70.4

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.3

70.3

276

668

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

18.4

70.2

110

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

18.8

68.9

107

NF1DA

NOMESCO Finland

X-ray of hips

6.7

68.0

180

277

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

3.6

67.7

329

961

M01AB55

ATC

diclofenac, combinations; oral

3.1

67.3

400

1355

B01AB05

ATC

enoxaparin; parenteral

1.8

67.1

1440

8997

SPAT1325

SPAT

Vaccination

1.8

67.1

1621

10521

9522

FHL

Synovectomy

46.2

66.9

D02AE01

ATC

carbamide; topical

2.8

66.5

475

1818

R50.9

ICD-10 Finland

Fever, unspecified

2.1

66.4

819

4150

NDF10

NOMESCO Finland

Synovectomy of wrist

69.9

66.3

S18

ICPC

Laceration/cut

1.7

65.4

2045

14296

P01AB01

ATC

metronidazole; oral, rectal

1.7

65.4

2184

15552

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

65.2

1242

7443

9503

FHL

Tendon or tendon sheath cleansing surgery (tenosynovectomy)

38.3

65.2

3029

Kela drug reimbursment

Upadacitinib

101.3

64.0

D07AB08

ATC

desonide; topical

2.3

63.8

676

3195

A02BC01

ATC

omeprazole; systemic

1.8

63.3

1351

8397

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

51.3

63.2

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

5.0

63.1

211

433

M07.0

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

57.6

62.8

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

20.3

62.3

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

62.2

991

5554

WX204

NOMESCO Finland

Axillary plexus blockaced

4.0

61.9

258

660

M01AX17

ATC

nimesulide; oral

1.9

61.9

1168

6962

A04AA01

ATC

ondansetron; systemic, rectal

2.8

61.8

422

1565

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

61.4

1893

13121

M05BA07

ATC

risedronic acid; oral

5.3

60.3

190

365

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

60.2

455

1796

R4180

NOMESCO Finland

Podiatric therapy

9.0

59.8

130

148

7143D

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]

46.2

59.6

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.8

59.5

405

1500

ZXA05

NOMESCO Finland

Left side

1.8

59.4

1178

7124

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.6

59.2

287

836

D06BB04

ATC

podophyllotoxin; topical

2.6

58.6

465

1886

WZA90

NOMESCO Finland

Other doctors statement

1.8

58.5

1369

8724

NHG22

NOMESCO Finland

Fusion of subtalar joint

11.9

57.9

108

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.7

57.7

263

728

RT271

NOMESCO Finland

24.4

57.6

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

7.5

57.3

139

189

TQW40

NOMESCO Finland

Remowal of suture of skin

2.6

57.1

454

1844

298

Kela drug reimbursment

151.5

57.0

NCF10

NOMESCO Finland

Synovectomy of elbow joint, open

60.7

56.5

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

7.4

56.4

138

190

N03AX16

ATC

pregabalin; oral

1.8

55.9

1190

7345

M17.5

ICD-10 Finland

Other secondary gonarthrosis

6.9

55.6

143

212

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.0

55.4

348

1224

J05AB11

ATC

valaciclovir; oral

2.0

55.2

749

3930

L34

ICPC

Musculoskeletal, Blood test

70.6

55.2

D94

ICPC

Chronic enteritis/ulcerative colitis

9.8

55.1

114

119

D05AA

ATC

Tars

12.4

54.6

100

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

8.0

54.6

127

162

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

58.8

54.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

54.1

538

2453

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.9

53.8

156

271

NDG76

NOMESCO Finland

Fusion of DIP joint

10.7

53.8

106

101

J01CA04

ATC

amoxicillin; systemic

1.7

53.8

4589

40590

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

532.9

53.6

9256

FHL

Synovectomy (knee 9311)

36.2

52.9

RK220

NOMESCO Finland

14.5

52.7

EG1CG

NOMESCO Finland

Extensive MRI examination of mandipular joint with high intensity magnet

16.6

52.5

M13.8

ICD-10 Finland

Other specified arthritis

8.3

52.4

119

146

M19.2

ICD-10 Finland

Other secondary arthrosis

7.0

52.3

133

194

M08.8

ICD-10 Finland

Other juvenile arthritis

67.3

52.2

L20

ICPC

Joint symptom/complaint NOS

3.5

51.9

259

771

WW200

NOMESCO Finland

Immunization

3.8

51.7

229

618

R2110

NOMESCO Finland

Giving the first information

2.4

51.4

468

2041

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

6.2

50.9

142

235

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

27.2

50.8

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.5

50.4

431

1819

K50

ICD-10 Finland

Crohn disease [regional enteritis]

15.7

49.6

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

49.5

3764

31874

WX203

NOMESCO Finland

Infraclavicular plexus blockade

4.2

49.4

196

479

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

49.4

1115

6975

M05BX04

ATC

denosumab; parenteral

3.6

49.0

234

673

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

49.6

48.9

E000007

ATC

2.6

48.9

387

1566

3042

Kela drug reimbursment

43.3

48.5

253

Kela drug reimbursment

42.5

47.6

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

37.9

47.2

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

7.2

46.9

116

163

4AC07

NOMESCO Finland

102.9

46.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

46.7

607

3116

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

46.5

732

4050

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

10.5

46.4

SPAT1153

SPAT

Removal of sutures

1.6

46.4

1471

10104

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.2

46.4

258

834

NG2CA

NOMESCO Finland

X-ray of patella with specialised projection

11.5

45.9

R5120

NOMESCO Finland

Preparation of an aid

4.9

45.9

154

318

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.7

45.9

109

144

L04AC03

ATC

anakinra; parenteral

+∞

45.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

8.3

45.8

104

128

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.3

45.7

177

423

NH3AE

NOMESCO Finland

Feet ultrasound examination

19.1

45.7

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

4.2

45.7

179

433

J01MA12

ATC

levofloxacin; systemic

1.8

45.3

829

4831

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

29.3

45.2

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

5.7

45.2

133

236

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.7

45.1

334

1299

L04AA44

ATC

upadacitinib; oral

73.6

45.0

D02AX

ATC

Other emollients and protectives

3.2

45.0

255

833

Z50.1

ICD-10 Finland

Other physical therapy

2.7

44.8

320

1219

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

44.6

584

3004

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

44.5

672

3654

L73.2

ICD-10 Finland

Hidradenitis suppurativa

6.0

44.5

126

213

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.6

44.1

336

1327

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

23.6

44.0

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

48.6

43.9

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

7.7

43.7

104

138

L99

ICPC

Musculoskeletal disease other

4.7

43.7

153

331

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.2

43.1

171

419

JF1BD

NOMESCO Finland

Very extensive small bowel CT

11.1

42.6

M01AB01

ATC

indometacin; systemic, rectal

2.6

42.5

330

1318

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

16.8

42.4

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.3

42.2

410

1843

H02AB09

ATC

hydrocortisone; systemic

3.8

42.1

188

512

J01AA02

ATC

doxycycline; systemic

1.5

42.0

3998

34811

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

42.0

685

3828

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

42.0

295

1112

4AA24

NOMESCO Finland

92.8

41.8

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

92.8

41.8

M05BA06

ATC

ibandronic acid; systemic

5.8

41.3

121

214

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

6.2

41.2

113

184

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

4.1

41.1

168

423

J01FA10

ATC

azithromycin; systemic

1.5

40.8

3320

27875

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

4.5

40.7

148

333

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

40.6

1553

11100

9284

FHL

Wrist ossification surgery

39.6

40.6

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.0

40.1

168

433

S01FA04

ATC

cyclopentolate; ophthalmic

6.5

40.0

106

165

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

39.9

999

6397

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

38.8

39.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

39.4

1711

12578

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

39.1

658

3710

ND1AE

NOMESCO Finland

Wrist ultrasound examination

14.9

38.8

M01CC01

ATC

penicillamine; oral

38.0

38.7

TNB10

NOMESCO Finland

Joint puncture, shoulder joint

22.6

38.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

38.6

429

2053

XQ848

NOMESCO Finland

Dermatological photography

3.9

38.6

163

423

ZZH31

NOMESCO Finland

Bone allograft, small pieces

8.0

38.6

113

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

38.4

247

879

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

38.3

341

1464

ZXA10

NOMESCO Finland

Bilateral

1.7

38.3

829

5077

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

38.2

301

1211

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.6

37.9

181

521

A02BA02

ATC

ranitidine; systemic

1.7

37.8

831

5108

N03AX12

ATC

gabapentin; oral

1.8

37.8

754

4502

NHG82

NOMESCO Finland

Fusion of other tarsal joint

7.4

37.7

124

M02AA07

ATC

piroxicam; topical

1.5

37.7

1610

11766

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

12.0

37.5

RT171

NOMESCO Finland

21.3

37.4

4AA33

NOMESCO Finland

36.4

36.8

M08.2

ICD-10 Finland

Juvenile arthritis with systemic onset

82.7

36.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

36.8

907

5765

J02AC01

ATC

fluconazole; systemic

1.5

36.7

2150

16769

NDG74

NOMESCO Finland

Fusion of first IP joint

16.6

36.7

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.8

36.4

249

922

E000006

ATC

2.2

36.1

394

1866

P01BA01

ATC

chloroquine; systemic

13.9

36.0

M01AB08

ATC

etodolac; oral

2.2

35.8

399

1908

7143B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SEROPOSITIVA]

127.5

35.7

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

4.2

35.7

140

340

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

35.6

310

1317

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

40.3

35.2

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

35.1

2184

17194

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

34.9

240

890

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

34.9

860

5461

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

34.9

2572

20903

M79.7

ICD-10 Finland

Fibromyalgia

2.9

34.9

225

805

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.2

34.8

136

329

NDF68

NOMESCO Finland

Operation for osteochondritis of several joints of hand, open

78.6

34.8

1XC02

NOMESCO Finland

7.8

34.7

105

M05.0

ICD-10 Finland

Felty syndrome

36.9

34.6

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.7

34.6

155

424

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

34.6

479

2509

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

25.5

34.4

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

9.0

34.2

NDL66

NOMESCO Finland

Transposition of tendon of wrist or hand, other tendon

14.3

34.1

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

5.7

34.1

100

178

EG1AA

NOMESCO Finland

Mandibular joint X-ray examination

8.9

33.9

M66.0

ICD-10 Finland

Rupture of popliteal cyst

5.9

33.8

164

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

33.6

2781

23024

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.4

33.5

293

1246

D05AX05

ATC

tazarotene; topical

21.5

33.4

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

33.4

1228

8628

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

9.8

33.4

RS221

NOMESCO Finland

4.1

33.1

132

326

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

33.1

2006

15659

SPAT1251

SPAT

Organisation of medication

3.1

33.1

188

616

M03BX02

ATC

tizanidine; oral

1.4

33.0

3336

28593

JFB00

NOMESCO Finland

Partial resection of small intestine

5.3

32.8

102

195

NHB10

NOMESCO Finland

Primary partial prosthetic replacement of ankle joint

35.2

32.7

B03BA03

ATC

hydroxocobalamin; parenteral

2.7

32.7

228

855

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

32.7

1044

7088

-1

NOMESCO Finland

1.4

32.4

1891

14637

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.7

32.3

226

851

RT310

NOMESCO Finland

25.2

32.2

NHG20

NOMESCO Finland

Fusion of talocrural joint

8.1

31.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

31.5

1805

13896

M16.7

ICD-10 Finland

Other secondary coxarthrosis

6.9

31.4

115

QDH05

NOMESCO Finland

Correction of deformity of toe nail

13.2

31.3

J01DA01

ATC

[U] cefalexin; systemic

1.4

31.0

3218

27554

M06.3

ICD-10 Finland

Rheumatoid nodule

25.5

30.9

NHF15

NOMESCO Finland

Synovectomy of ankle, arthroscopic

18.9

30.8

Z71.8

ICD-10 Finland

Other specified counselling

1.5

30.8

1252

8975

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

30.8

1296

9361

K02.1

ICD-10 Finland

Caries of dentine

1.4

30.6

3191

27310

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

12.0

30.6

7148X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Other specified inflammatory polyarthropathies

46.5

30.6

M43.4

ICD-10 Finland

Other recurrent atlantoaxial subluxation

35.7

30.5

JFB20

NOMESCO Finland

Ileocaecal resection

9.8

30.5

TEG00

NOMESCO Finland

Punction of mandibular joint

20.6

30.4

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.1

30.3

369

1833

M05BA01

ATC

etidronic acid; systemic

17.5

30.0

RK210

NOMESCO Finland

11.1

29.9

ZX114

NOMESCO Finland

Intramuscular

4.3

29.7

114

272

9531

FHL

Arthrodesis of the hand joint

16.1

29.7

H02BX01

ATC

methylprednisolone, combinations; systemic

2.6

29.7

224

878

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.7

29.6

133

366

L28

ICPC

Limited function/disability (L)

1.8

29.5

554

3229

R06AE07

ATC

cetirizine; oral

1.4

29.5

2325

18916

L04AA33

ATC

vedolizumab; parenteral

50.3

29.3

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

29.2

308

1437

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

29.2

512

2918

K60.3

ICD-10 Finland

Anal fistula

3.5

29.0

140

408

M06.1

ICD-10 Finland

Adult-onset Still disease

31.9

29.0

9283

FHL

Subtalar joint ossification surgery (or triple)

31.9

29.0

J01FA09

ATC

clarithromycin; systemic

1.4

29.0

1672

12844

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

28.9

488

2743

318

Kela drug reimbursment

Teriparatide

11.9

28.8

L40.4

ICD-10 Finland

Guttate psoriasis

8.8

28.8

4AC05

NOMESCO Finland

150.7

28.7

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

28.4

3143

27002

3AC01

NOMESCO Finland

5.1

28.3

177

A02BB01

ATC

misoprostol; oral

10.9

28.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

28.1

804

5286

RJ512

NOMESCO Finland

31.0

28.1

L17

ICPC

Foot/toe symptom/complaint

1.5

28.1

1135

8102

RF120

NOMESCO Finland

4.6

27.8

220

S97

ICPC

Chronic ulcer skin

2.5

27.8

219

881

M46.0

ICD-10 Finland

Spinal enthesopathy

20.6

27.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

27.7

280

1282

J01FA06

ATC

roxithromycin; oral

1.4

27.5

1945

15469

RS222

NOMESCO Finland

4.5

27.4

223

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

27.4

2878

24452

9272

FHL

Metatarsophalangeal joint resection

19.7

27.3

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.8

27.3

193

RJ411

NOMESCO Finland

7.6

27.2

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

27.2

1279

9416

WX110

NOMESCO Finland

Local anesthesy

1.4

27.1

3739

33178

L88

ICD-10 Finland

Pyoderma gangrenosum

16.7

27.0

H26.3

ICD-10 Finland

Drug-induced cataract

7.2

27.0

NGF10

NOMESCO Finland

Total synovectomy of knee, open

21.8

26.9

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

6.1

26.8

123

M35.7

ICD-10 Finland

Hypermobility syndrome

3.7

26.8

119

325

L04AC18

ATC

risankizumab; parenteral

41.4

26.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

26.7

262

1181

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

26.6

3889

34781

JF1AD

NOMESCO Finland

Small bowel CT

8.8

26.6

H05AA02

ATC

teriparatide; parenteral

11.8

26.6

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

24.8

26.5

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

26.4

209

845

NH1AD

NOMESCO Finland

Ankle and foot CT

3.2

26.4

144

461

Z01.2

ICD-10 Finland

Dental examination

1.4

26.3

2212

18074

M01AB05

ATC

diclofenac; systemic, rectal

1.4

26.2

3396

29734

A46

ICD-10 Finland

Erysipelas

1.7

26.2

539

3227

NFC40

NOMESCO Finland

Repair of hip prosthesis by bone transplant to acetabulum

14.3

26.1

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.3

26.1

133

406

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

5.9

26.0

124

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

5.8

25.8

129

K51

ICD-10 Finland

Ulcerative colitis

4.4

25.8

214

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

25.8

133

409

M09.0*L40.5

ICD-10 Finland

Juvenile arthritis in psoriasis

73.0

25.8

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.0

25.7

324

1630

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

12.5

25.7

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

5.5

25.5

139

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

25.5

331

1686

M25.4

ICD-10 Finland

Effusion of joint

4.2

25.4

236

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

25.3

316

1584

M12.3

ICD-10 Finland

Palindromic rheumatism

12.6

25.3

K71

ICPC

Rheumatic fever/heart disease

50.2

25.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.0

25.2

146

488

SPAT1301

SPAT

No procedures

1.4

25.2

1408

10697

9311

FHL

Knee cleansing surgery (synovectomy, debridement)

19.1

25.2

L04AB02

ATC

infliximab; parenteral

+∞

25.0

L50

ICPC

Musculoskeletal, Medication/prescr/renewal

8.2

25.0

SPAT1263

SPAT

Sampling

1.4

25.0

2046

16603

RF420

NOMESCO Finland

3.9

25.0

104

269

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

12.2

25.0

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.2

24.9

263

1230

M05BB03

ATC

alendronic acid and colecalciferol; oral

4.1

24.9

246

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

24.8

1000

7111

RF410

NOMESCO Finland

4.1

24.8

237

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

24.8

397

2190

9527

FHL

Alloarthroplasty, implant or endoprosthesis

90.5

24.6

S01FA02

ATC

scopolamine; ophthalmic

5.7

24.6

125

M02AA10

ATC

ketoprofen; topical

1.6

24.6

690

4504

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

24.6

667

4315

D05AC01

ATC

dithranol; topical

43.0

24.5

RJ421

NOMESCO Finland

9.2

24.4

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

24.4

24.3

SPAT1255

SPAT

Intravenous administration of medicine

2.1

24.3

298

1483

7143X

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]

48.5

24.3

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

48.5

24.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

24.2

336

1758

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.1

24.1

135

441

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.1

24.0

134

437

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

23.9

629

4036

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.7

23.9

164

612

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

23.8

1211

9021

N02AA05

ATC

oxycodone; systemic

1.7

23.8

483

2877

SPAT1229

SPAT

Assessment of need for aid

2.1

23.8

285

1405

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

23.6

135

446

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

23.6

197

820

J05AB01

ATC

aciclovir; systemic

1.5

23.6

989

7083

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

23.6

321

1668

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

23.5

165

624

NHF80

NOMESCO Finland

Operation for debridement of toe joint, open

23.7

23.4

NBF15

NOMESCO Finland

Humeroscapular synovectomy, arthroscopic

14.5

23.4

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

23.3

614

3937

NHM99

NOMESCO Finland

Other operation on fascia, ganglion, synovial sheath or bursa of ankle or foot

6.3

23.3

M81.4

ICD-10 Finland

Drug-induced osteoporosis

8.5

23.0

M01AE52

ATC

naproxen and esomeprazole; oral

2.5

23.0

190

788

H20

ICD-10 Finland

Iridocyclitis

7.3

22.9

ACC51

NOMESCO Finland

Release of median nerve

1.9

22.9

347

1877

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

22.6

464

2771

4AA17

NOMESCO Finland

230.8

22.6

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.5

22.6

106

304

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.6

22.5

102

285

-50

ICPC

Medication/prescr/renewal

2.4

22.5

195

828

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.1

22.5

140

R01AD09

ATC

mometasone; nasal

1.3

22.4

2346

19674

RJ511

NOMESCO Finland

13.1

22.4

ND2AE

NOMESCO Finland

Hand and fingers ultrasound examination

13.1

22.4

RJ410

NOMESCO Finland

7.4

22.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

22.3

1236

9339

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

22.2

657

4338

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

9.3

22.2

L40.1

ICD-10 Finland

Generalized pustular psoriasis

23.9

22.1

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

15.1

21.9

NC1AE

NOMESCO Finland

Elbow ultrasound examination

15.1

21.9

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

4.5

21.9

175

NF1AT

NOMESCO Finland

Puncture of hip joint with ultrasound guidance

9.6

21.7

N06AX21

ATC

duloxetine; oral

1.7

21.7

532

3345

R06.0

ICD-10 Finland

Dyspnoea

1.5

21.7

957

6913

N06AA09

ATC

amitriptyline; systemic

1.8

21.7

414

2418

L01BB01

ATC

14.5

21.6

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.5

21.5

A07AA09

ATC

vancomycin; oral

4.4

21.5

178

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

21.5

1981

16271

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

21.4

105

312

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

11.9

21.4

JHA00

NOMESCO Finland

Anal or perianal incision

3.5

21.4

102

297

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

10.9

21.1

M01AH03

ATC

valdecoxib; oral

2.0

21.1

291

1522

M02.8

ICD-10 Finland

Other reactive arthropathies

7.3

20.9

R01AD12

ATC

fluticasone furoate; nasal

1.4

20.9

1606

12807

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

20.9

454

2758

NDG20

NOMESCO Finland

Fusion of wrist, partial

6.7

20.8

TEG10

NOMESCO Finland

Injection of diagnostic or therapeutic substance into mandibular joint

12.4

20.8

B07.9

ICD-10 Finland

Verruca simplex

2.3

20.8

198

882

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

20.7

290

4846

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

20.7

193

853

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.8

20.7

145

L04AA14

ATC

[U] anakinra; parenteral

210.7

20.6

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.5

20.6

159

637

B02.9

ICD-10 Finland

Zoster without complication

2.2

20.6

222

1046

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

20.5

492

3074

TNF10

NOMESCO Finland

Puncture of hip joint

18.3

20.4

RJ420

NOMESCO Finland

8.5

20.3

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

10.1

20.3

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

20.2

315

1719

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

20.1

146

565

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

20.1

565

3680

R03AC02

ATC

salbutamol; inhalant

1.3

20.1

2623

22576

NCF15

NOMESCO Finland

Synovectomy of elbow joint, arthroscopic

57.7

19.9

H57.1

ICD-10 Finland

Ocular pain

2.4

19.8

176

759

RT350

NOMESCO Finland

12.6

19.8

9289

FHL

Other measure in this category

35.9

19.8

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

19.8

656

4448

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

19.6

523

3362

B01AB04

ATC

dalteparin; parenteral

2.2

19.6

203

942

NDB20

NOMESCO Finland

Primary total prosthetic replacement of joint of wrist not using cement, all parts

200.6

19.6

H221, M083

ICD-10 Finland

200.6

19.6

J01MA14

ATC

moxifloxacin; systemic

1.8

19.5

374

2187

M54.5

ICD-10 Finland

Low back pain

1.3

19.5

1587

12738

NDG71

NOMESCO Finland

Arthrodes of first MP joint

9.8

19.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

19.5

2525

21673

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.7

19.5

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

3.2

19.4

105

337

EG1DG

NOMESCO Finland

Very extensive MRI examination of mandipular joint with high intensity magnet

14.6

19.3

9294

FHL

Endoprosthesis replacement of the entire hip joint (eg Charnley)

10.6

19.3

9269

FHL

Other measure in this category

12.7

19.3

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.9

19.3

304

1666

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

19.0

172

748

K61.0

ICD-10 Finland

Anal abscess

3.0

18.9

111

377

-44

ICPC

Preventive immunization/medic

1.8

18.9

329

1866

J04AB02

ATC

rifampicin; systemic

4.3

18.9

164

D07AA02

ATC

hydrocortisone; topical

1.5

18.9

691

4791

RK120

NOMESCO Finland

10.6

18.9

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

8.7

18.8

RT274

NOMESCO Finland

10.1

18.8

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

18.7

426

2623

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

18.7

202

955

C07AB07

ATC

bisoprolol; oral

1.3

18.7

1629

13199

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

27.9

18.7

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.4

18.7

162

691

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

18.7

18.6

RT160

NOMESCO Finland

10.3

18.6

J01CF05

ATC

flucloxacillin; systemic

2.2

18.6

183

829

H26.2

ICD-10 Finland

Complicated cataract

3.8

18.5

206

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

18.5

4952

46957

H15.1

ICD-10 Finland

Episcleritis

3.2

18.5

316

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

3.2

18.4

317

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

12.9

18.4

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

18.3

628

4287

RJ210

NOMESCO Finland

10.1

18.3

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

18.2

220

1091

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

17.6

18.2

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.9

18.2

110

379

SPAT1204

SPAT

Arthrocentesis

5.2

18.1

109

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

7.0

18.0

L15

ICPC

Knee symptom/complaint

1.4

18.0

869

6372

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.7

17.9

124

467

SBB10

NOMESCO Finland

Teeth copy

1.7

17.8

365

2180

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.9

17.8

274

1492

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

17.7

866

6360

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

17.7

335

1952

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

+∞

17.7

S01BC03

ATC

diclofenac; ophthalmic

2.8

17.6

117

429

RF210

NOMESCO Finland

2.4

17.6

152

647

R11

ICD-10 Finland

Nausea and vomiting

1.7

17.6

351

2081

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

12.5

17.6

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.4

17.6

148

620

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.1

17.4

583

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

13.1

17.4

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

17.4

2843

25011

R60.0

ICD-10 Finland

Localized oedema

1.7

17.3

379

2309

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

24.1

17.3

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

17.3

2096

17738

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

17.2

449

2867

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

17.2

1981

16647

TGC00

NOMESCO Finland

Bronchial lavation

2.8

17.2

112

408

R05

ICD-10 Finland

Cough

1.4

17.2

807

5881

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

17.1

100

339

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

8.5

17.1

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

8.8

17.1

D05AX

ATC

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3024561) Albumin [Mass/volume] in Serum or Plasma

3701

21220

2.59

323.31

8.1

4.9

g/l

36.1

36.5

4.23

3551

19876

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

783

1824

4.71

312.16

1.7

2.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

308

457.73

310.00

2.5

2.3

mg/l

3.0

3.8

—

299

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2528

12268

2.67

309.43

3.5

2.1

mg/l

3.0

2.8

3.34

2337

10581

(3001604) Monocytes [#/volume] in Blood

6796

27897

62.31

307.65

18.6

5.7

e9/l

0.6

37.89

6690

24295

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4600

22451

4.09

307.65

3.4

2.3

nmol/l

75.2

74.6

0.85

4468

20782

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

915

1086

9.55

307.65

4.5

3.7

55.0

56.9

3.42

915

1086

(3013115) Eosinophils [#/volume] in Blood

6813

29007

65.29

307.65

19.2

6.0

e9/l

0.2

0.16

6731

25714

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1064

1095

11.29

307.65

1.9

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

2439

8016

4.14

307.65

7.6

2.3

ug/g

248.4

112.8

47.45

2245

6376

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1111

610

21.48

307.65

1.1

iu/ml

1.5

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6823

41192

34.59

307.65

17.6

7.0

u/l

71.0

76.0

30.04

6803

39008

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

642

217

32.49

307.65

3.1

3.7

mg/l

8.6

8.2

0.38

503

172

(3019069) Monocytes/100 leukocytes in Blood

6333

26325

16.63

307.65

19.4

6.1

8.9

8.3

59.14

6310

24813

(40760892) CBC W Ordered Manual Differential panel - Blood

3622

13436

4.54

307.65

11.2

4.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

609

502

13.20

307.65

2.2

1.5

47.5

56.0

3.34

439

300

(3025159) Blasts/100 leukocytes in Blood

2050

3854

7.12

307.65

6.8

4.3

0.0

0.2

1.01

464

848

(3013707) Erythrocyte sedimentation rate by Westergren method

6780

41078

26.29

307.65

13.8

3.6

mm/h

11.8

10.0

26.34

6720

38517

(3006504) Eosinophils/100 leukocytes in Blood

6314

26171

16.24

307.65

19.0

5.8

2.9

2.8

0.19

6288

24498

(3044941) Cell count panel - Synovial fluid

685

646

11.65

307.65

1.9

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1563

4418

4.27

307.65

2.8

2.7

g/l

10.7

10.4

1.38

1475

4058

(3037522) Nuclear Ab [Titer] in Serum

2999

8206

5.67

307.65

1.5

1.4

titre

459.3

538.0

1.66

771

1578

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3210

11898

4.15

307.65

1.5

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

2099

4057

6.98

307.65

6.8

4.3

0.0

0.2

2.85

523

1014

(3021589) Normoblasts [#/volume] in Blood

5090

25022

4.85

307.65

20.1

8.6

e9/l

0.0

1.64

4888

20404

(3021601) Nitrite [Presence] in Urine by Test strip

5111

27038

4.35

307.65

7.3

4.3

estimate

0.0

0.80

1341

5150

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

465

385

12.87

307.65

2.1

1.5

42.0

31.6

4.16

329

228

(3002179) Metamyelocytes/100 leukocytes in Blood

2076

3887

7.19

307.65

5.8

4.0

0.3

0.6

9.28

430

806

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1477

1041.37

307.65

2.1

1.1

mg/l

9.3

0.01

1187

(3037467) Urinalysis macro (dipstick) panel - Urine

5996

37618

5.29

307.65

8.2

3.8

—

(3017181) Myelocytes/100 leukocytes in Blood

2191

4243

7.08

307.65

6.6

4.2

0.5

0.9

10.89

556

1095

(46235355) HIV 1 and 2 tests - Meaningful Use set

2938

14900

2.68

307.65

1.6

2.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

793

534

16.63

307.65

1.3

1.5

iu/ml

29.3

27.7

0.05

(3006315) Basophils [#/volume] in Blood

6808

27995

66.99

307.65

18.8

5.7

e9/l

0.0

25.94

6709

24356

(3022096) Basophils/100 leukocytes in Blood

6261

25319

15.68

307.65

19.1

5.9

0.8

0.7

36.67

6237

23728

(3022145) Colonoscopy Study observation

1772

5931

3.67

307.65

2.1

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

5101

26938

4.35

307.65

5.6

3.2

estimate

0.0

1.28

1255

4969

(3002030) Lymphocytes/100 leukocytes in Blood

6341

27358

15.84

307.65

19.2

5.8

31.4

29.3

58.58

6315

25668

(3010144) Erythrocytes [#/volume] in Synovial fluid

400

376

11.23

307.65

1.9

1.3

e6/l

14633.7

66508.0

1.35

280

259

(3000475) Leukocytes [#/volume] in Synovial fluid

1011

973

11.99

307.65

2.3

1.5

e6/l

9650.6

12860.8

1.03

817

696

(3017143) Hepatitis C virus Ab [Presence] in Serum

2980

8406

5.45

307.65

1.4

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

6797

28935

58.95

307.65

18.9

5.7

e9/l

2.1

2.0

11.64

6717

25723

(40758558) Short blood count panel - Blood

3124

13995

3.24

307.65

13.9

6.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1189

3430

3.97

307.65

1.6

1.9

g/l

1.3

0.10

1123

3172

(42870588) Differential panel, method unspecified - Blood

5484

18238

10.47

307.65

15.6

5.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6835

32119

64.31

307.65

21.2

9.0

e9/l

3.8

4.0

12.88

6741

28105

(3018010) Neutrophils/100 leukocytes in Blood

6332

26968

15.96

307.65

18.4

5.7

54.4

56.3

38.28

6305

25403

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

917

2294

4.45

307.65

1.3

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

5124

27268

4.33

307.65

5.6

3.2

estimate

0.0

0.46

1303

4965

(3011397) Hemoglobin [Presence] in Urine by Test strip

2763

12206

3.10

307.65

5.6

3.2

—

(3021788) Differential panel - Synovial fluid

820

749

12.28

307.65

2.1

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

593

206

31.37

307.65

2.6

3.0

au/ml

154.5

116.1

0.55

119

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2170

5406

5.38

307.65

1.2

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2984

1587

32.17

307.65

1.6

iu/ml

5.1

0.3

0.53

711

299

(3018095) Leukocytes [#/volume] in Urine

3512

18100

2.90

307.65

4.5

3.4

e6/l

38.3

78.5

4.34

2412

12408

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1224

3302

4.28

307.65

2.2

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

2757

14182

2.56

296.49

6.9

3.5

estimate

0.0

3.07

1328

4989

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

178

34.44

281.08

3.3

3.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2112

9766

2.67

280.34

1.4

1.3

u/ml

51.9

8.9

18.72

906

4049

(3015171) Extractable nuclear Ab [Units/volume] in Serum

865

2362

4.04

278.94

1.3

u/ml

0.2

1.1

3.14

204

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3582

21225

2.42

277.30

6.2

3.2

—

(3008898) HLA-B27 [Presence]

900

2560

3.89

273.79

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6926

58433

40.07

267.80

30.5

11.4

mg/l

14.0

21.4

140.57

6487

44914

(3034891) Synovial lining cells/100 cells in Synovial fluid

261

213

12.69

265.28

1.9

1.4

4.6

4.4

0.05

(3000850) Epithelial cells [#/volume] in Urine

2125

10295

2.53

251.84

2.8

2.5

e6/l

4.7

6.3

7.24

1924

9010

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

558

1198

4.98

244.04

2.5

6.2

iu/ml

472.4

788.2

0.56

167

(3030467) Casts [#/volume] in Urine by Automated count

2533

13803

2.31

225.93

3.5

2.9

e6/l

0.2

0.4

2.44

2075

10174

(3002582) Erythrocytes [#/volume] in Urine

2675

15068

2.26

218.80

3.5

3.0

e6/l

25.0

88.6

4.40

2237

11355

(3002385) Erythrocyte distribution width [Ratio]

6224

50061

3.30

217.57

31.8

14.0

13.7

13.5

45.20

6214

49066

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

207

+∞

216.79

1.3

0.0

mg/l

1.6

—

175

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2049

10407

2.37

213.04

1.3

iu/ml

87.0

25.7

8.81

858

3186

(3041096) Erythrocytes [Presence] in Urine by Automated

2695

15482

2.21

207.42

4.7

2.8

—

(36304419) Bacteria [Presence] in Urine

2473

13735

2.24

206.85

3.3

2.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3687

24046

2.13

203.33

6.1

6.7

mmol/l

1.2

0.99

3133

20425

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

596

1552

4.11

203.18

1.1

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1553

7147

2.51

199.21

2.4

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1626

7670

2.46

197.51

2.5

umol/l

12.9

14.1

7.75

1560

7156

(3018418) pH of Serum or Plasma

2489

14183

2.18

192.26

3.4

4.1

7.4

0.10

509

2809

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1425

6464

2.51

187.34

2.5

2.6

21.5

23.9

7.51

1238

5618

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1484

7037

2.41

175.90

2.4

2.5

g/l

2.4

0.10

1415

6557

(3023368) Bacteria identified in Blood by Culture

2163

12032

2.16

174.35

4.6

4.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

588

1686

3.72

174.20

1.3

titre

85.5

124.0

0.57

171

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6930

61865

29.84

173.55

28.4

12.7

umol/l

71.2

73.3

11.93

6930

61844

(3024263) Appearance of Synovial fluid

207

225

9.45

172.60

3.9

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3320

21796

2.00

168.73

5.5

6.0

mmol/l

1.2

1.36

3142

19957

(3019150) Specific gravity of Urine by Refractometry

2107

11728

2.14

168.54

6.9

3.4

kg/l

1.0

0.04

237

1691

(3034770) Mitochondria Ab [Titer] in Serum

575

1663

3.68

168.04

1.3

titre

957.5

1161.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

2207

12519

2.12

167.90

1.6

1.5

g/l

2.7

2.3

19.69

1577

7965

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1640

8336

2.27

164.07

2.7

2.6

e6/l

0.8

1.1

2.19

1082

4531

(3004809) Band form neutrophils/100 leukocytes in Blood

348

697

5.20

164.06

2.6

3.3

0.9

1.4

3.04

271

557

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6930

62251

28.17

163.32

30.6

9.0

u/l

28.5

27.6

3.77

6924

60477

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6352

54003

3.02

155.38

21.2

10.2

ml/min/173m2

93.3

88.9

58.41

5863

44277

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3809

26883

1.92

149.70

5.6

6.1

umol/l

10.0

10.8

4.46

3666

25484

(3009871) Measles virus Ab [Titer] in Serum

186

213

8.94

148.93

1.8

1.7

—

(40761535) Cells panel - Urine sediment

916

3820

2.61

140.58

6.5

3.2

—

(3017732) Neutrophils [#/volume] in Blood

942

3984

2.58

140.44

3.9

2.6

e9/l

4.1

0.20

778

3281

(3009445) Proteinase 3 Ab [Units/volume] in Serum

627

2182

3.06

135.24

1.5

1.7

u/ml

11.8

13.6

0.13

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2884

19377

1.83

124.50

4.2

3.2

u/l

33.9

32.8

0.28

2742

18460

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3646

26404

1.80

121.64

3.7

2.8

ug/l

110.4

104.9

0.58

3513

24901

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

125

110

11.55

120.77

1.8

1.2

42.1

34.2

1.06

(3007853) Bacteria identified in Skin by Aerobe culture

1244

6365

2.16

118.20

1.9

1.7

—

(3045414) Leukocytes [Presence] in Urine

622

2356

2.80

114.41

1.9

1.8

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

126

124

10.33

112.83

1.9

1.3

42.1

52.9

1.77

113

108

(3017354) Segmented neutrophils/100 leukocytes in Blood

220

409

5.52

112.42

2.6

3.3

54.7

57.7

1.00

138

267

(3000494) Fungus identified in Specimen by Culture

1221

6445

2.08

105.86

1.5

—

(3026782) Osmolality of Urine

1633

9557

1.93

105.53

3.2

2.6

mosm/kgh2o

541.1

548.6

0.66

1454

8164

(3031040) Bacteria [#/volume] in Urine by Automated count

4483

35275

1.76

105.07

5.0

3.8

e6/l

1206.4

1206.7

0.00

401

(3032080) INR in Blood by Coagulation assay

2684

18341

1.75

104.16

6.2

6.9

inr

1.1

1.2

6.15

976

5678

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

503

1799

2.94

102.62

1.6

1.8

g/l

0.2

1.65

471

1701

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

511

1856

2.89

101.33

1.6

1.8

g/l

1.2

0.52

478

1759

(3014148) Varicella zoster virus Ab [Titer] in Serum

338

1000

3.50

94.55

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

486

1796

2.83

93.16

1.7

titre

464.0

362.0

0.27

(3027945) Reticulocytes/100 erythrocytes in Blood

924

4637

2.14

90.41

3.5

2.8

1.8

1.7

1.06

854

4163

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

+∞

88.72

1.2

0.0

mg/l

28.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1035

5464

2.05

88.37

2.1

2.2

nmol/l

317.5

371.8

17.71

988

5046

(3025941) Bacteria identified in Stool by Culture

762

3581

2.27

87.64

1.4

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

425

1519

2.91

86.53

2.4

2.9

—

(3045424) Erythrocytes [Presence] in Urine

302

885

3.52

85.66

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

335

1052

3.29

85.19

1.1

—

(40761536) Microorganisms panel - Urine sediment

924

4767

2.08

83.66

4.7

3.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

205

463

4.53

83.41

2.8

3.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

297

885

3.46

82.07

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2039

13588

1.71

82.04

2.5

2.4

umol/l

1895.0

3278.5

1.81

1857

12111

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2376

16493

1.67

81.92

3.4

2.6

u/l

58.1

57.1

0.32

2244

15327

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

391

1392

2.92

80.09

1.5

iu/ml

6.2

15.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

372

1295

2.98

79.33

2.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

399

1444

2.87

79.30

1.8

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1240

7236

1.87

78.03

1.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

882

4688

2.01

72.95

3.2

2.4

g/l

0.2

3.69

841

4410

(3024980) IgG subclass 4 [Mass/volume] in Serum

308

1033

3.07

70.04

1.5

1.6

g/l

0.5

0.8

4.38

227

777

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

326

1132

2.97

69.75

1.5

1.3

—

(40768443) Skin Pathology biopsy report

513

2237

2.40

69.64

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

1220

7338

1.80

68.72

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

578

2682

2.26

67.88

1.7

2.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

394

1543

2.65

67.12

1.3

u/ml

4.4

9.4

1.91

251

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

390

1525

2.65

66.64

1.3

u/ml

9.7

5.1

0.30

155

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1271

7824

1.76

65.87

3.0

2.7

e6/l

2.8

2.9

0.20

717

4038

(3048929) Epstein Barr virus Ab [Presence] in Serum

543

2492

2.28

65.40

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

416

1698

2.54

65.08

1.3

u/ml

24.0

34.8

0.37

107

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

64.67

1.2

0.0

au/ml

341.0

—

(3007461) Platelets [#/volume] in Blood

6939

66381

16.77

64.67

41.2

16.9

e9/l

275.9

257.4

98.28

6928

64932

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2593

19202

1.56

64.28

2.0

1.8

pmol/l

92.4

98.0

8.42

1649

10200

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

890

4946

1.92

64.13

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

207

574

3.69

63.73

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6315

57690

2.02

62.92

16.2

12.5

mmol/l

139.3

139.7

34.42

6200

56261

(3026361) Erythrocytes [#/volume] in Blood

6939

66456

16.36

62.91

41.1

16.8

e12/l

4.5

4.6

55.86

6924

64897

(3023103) Potassium [Moles/volume] in Serum or Plasma

6333

57928

2.04

62.63

16.3

12.6

mmol/l

3.9

23.22

6201

56371

(3010813) Leukocytes [#/volume] in Blood

6939

66472

16.27

62.53

41.2

16.9

e9/l

7.0

6.6

44.73

6925

64886

(3023520) Reticulocytes [#/volume] in Blood

656

3319

2.08

61.64

2.2

2.9

e9/l

75.1

71.3

1.58

505

2452

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

242

768

3.23

60.38

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

106

7.82

59.44

1.2

g/l

40.7

38.5

0.50

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

865

4881

1.88

59.18

1.6

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1535

10210

1.65

58.89

1.6

1.5

nmol/l

20.7

20.4

0.19

1391

8964

(3020630) Protein [Mass/volume] in Serum or Plasma

656

3386

2.03

58.25

1.9

2.7

g/l

67.7

67.0

1.37

609

3138

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

176

465

3.86

58.11

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

176

465

3.86

58.11

1.3

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3751

30473

1.50

58.04

4.8

4.6

mmol/l

6.4

6.5

3.97

3548

28139

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

176

466

3.85

57.94

1.3

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

117

226

5.25

57.32

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

470

3.82

57.24

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

176

470

3.82

57.24

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

9.06

57.18

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

479

2205

2.26

57.09

1.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

176

471

3.81

57.07

1.3

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

313

1200

2.68

55.53

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

176

481

3.73

55.36

1.3

1.2

titre

242.0

183.5

0.48

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

176

481

3.73

55.36

1.3

titre

361.3

158.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

349

1420

2.53

54.85

1.2

1.3

u/ml

310.0

248.8

3.06

210

904

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

317

1231

2.65

54.82

1.3

u/ml

9.8

3.3

0.59

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

239

800

3.06

54.49

1.4

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1998

14362

1.55

54.47

1.3

u/ml

1.5

1.7

0.32

573

4072

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

867

5053

1.82

53.14

2.7

4.6

u/l

225.9

239.5

3.17

826

4807

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

359

1505

2.46

52.92

1.2

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

289

1097

2.71

52.27

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1187

7596

1.68

52.17

1.8

1.7

nmol/l

1170.8

1167.4

0.04

963

5910

(40761511) CBC panel - Blood by Automated count

6586

61713

2.25

51.88

20.4

10.6

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

11.60

51.57

1.1

1.2

u/ml

34.9

24.9

0.42

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

11.60

51.57

1.1

1.2

u/ml

25.7

20.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

366

1568

2.41

51.43

2.1

ug/l

1.6

2.1

0.42

320

1427

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

138

340

4.12

50.20

1.1

miu/ml

1530.9

1491.3

0.15

138

340

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

937

2.79

49.09

1.8

3.3

u/ml

723.0

1236.0

0.36

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

192

5.16

47.29

1.5

2.0

u/ml

3471.4

19594.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

353

1545

2.35

47.23

1.5

2.3

g/l

7.7

7.3

3.08

267

1187

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

1544

2.35

46.86

1.5

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

1544

2.35

46.86

1.5

2.3

g/l

4.3

3.8

5.79

261

1127

(3026008) Bacteria identified in Urine by Culture

1886

13783

1.51

46.08

3.1

2.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

171

526

3.31

44.92

1.2

u/l

51.7

62.2

1.47

132

361

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

393

1842

2.20

44.65

1.6

1.8

g/l

1.6

1.5

1.20

330

1598

(3014051) Protein [Presence] in Urine by Test strip

279

1138

2.51

43.57

2.4

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1443

10066

1.55

43.43

1.9

1.6

pmol/l

42341350.4

30506553.1

0.20

1273

8654

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

332

1468

2.32

43.37

1.5

2.4

g/l

3.3

3.1

3.26

262

1158

(3001729) Color of Synovial fluid

13.30

43.36

2.8

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

673

3862

1.82

42.95

2.8

3.9

mmol/l

1.2

0.26

621

3398

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

128

346

3.75

40.97

1.5

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1422

2.30

40.88

1.4

2.4

g/l

11.1

10.2

2.82

280

1225

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

281

1187

2.42

40.69

1.5

2.3

g/l

0.0

0.25

264

1110

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

301

1318

2.34

40.20

1.3

u/ml

46.5

40.4

0.22

127

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

159

5.21

40.06

1.4

1.5

ug/l

9.6

8.5

1.25

159

(40768804) Tissue Pathology biopsy report

2800

22547

1.40

39.23

2.2

1.9

—

(3037756) Immunofixation for Serum or Plasma

202

741

2.78

39.03

1.5

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

297

1319

2.31

38.39

1.6

2.4

g/l

0.3

0.8

4.55

270

1175

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

462

2449

1.95

37.58

1.6

2.0

u/l

37.4

39.5

1.62

434

2227

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1900

14418

1.44

36.63

1.8

1.6

—

(3011412) CD3 cells [#/volume] in Blood

174

613

2.89

36.27

1.8

2.5

e9/l

1.2

0.06

109

372

(4062490)

183

663

2.81

36.22

1.3

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3128

25905

1.38

35.94

4.4

3.8

—

(3000330) Specific gravity of Urine by Test strip

418

2187

1.97

35.29

3.6

2.9

—

(3033658) Prothrombin time (PT) actual/Normal

1812

13749

1.43

34.57

4.7

3.9

95.1

94.3

0.87

1768

13403

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

253

1097

2.36

34.56

1.4

2.3

g/l

0.0

0.00

236

1023

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1202

2.29

34.27

1.4

2.2

g/l

37.2

38.3

1.89

244

1063

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1916

14715

1.42

34.07

2.0

2.2

u/l

136.9

216.1

7.56

1829

13941

(3035611) Eosinophils/100 leukocytes in Synovial fluid

12.75

34.01

3.3

1.3

0.1

0.4

0.80

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

265

1185

2.29

33.70

1.4

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

1088

2.34

33.42

1.4

2.3

g/l

0.0

0.00

235

1021

(3027135) IgG subclass 1 [Mass/volume] in Serum

178

664

2.72

33.34

1.3

1.4

g/l

6.7

0.05

120

454

(3024139) IgG subclass 3 [Mass/volume] in Serum

178

664

2.72

33.34

1.3

1.4

g/l

0.4

0.21

121

451

(3028192) IgG subclass 2 [Mass/volume] in Serum

178

665

2.72

33.25

1.3

1.4

g/l

3.2

2.9

0.98

120

456

(3004616) Nuclear Ab [Presence] in Serum

182

689

2.69

33.13

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

194

762

2.59

32.80

1.3

u/ml

58.5

57.7

0.01

(3035947) Staphylolysin Ab [Units/volume] in Serum

232

4.01

32.53

1.1

iu/ml

3.8

3.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

438

2402

1.88

32.07

2.6

e6/l

0.2

0.85

422

2309

(3041672) Baker's yeast Ab [Presence] in Serum

9.78

32.07

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

140

471

3.01

31.73

1.8

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

760

4891

1.62

31.50

3.1

3.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

258

1177

2.24

31.29

1.4

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

243

1084

2.29

31.09

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

682

4303

1.65

30.56

2.3

au/ml

24.0

22.0

0.19

304

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

311

1565

2.03

29.28

1.6

2.1

mg/l

9.8

10.7

1.14

292

1472

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

104

307

3.42

29.27

1.1

1.2

u/l

77.1

89.1

0.74

267

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

287

1406

2.09

29.06

1.3

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2213

17781

1.36

28.89

3.1

3.0

ng/l

283.9

56.7

0.45

1275

9942

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

300

3.44

28.88

1.1

1.2

u/l

20.0

22.8

0.24

256

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

204

874

2.37

28.67

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

162

627

2.62

28.27

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

162

629

2.61

28.09

1.7

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

239

1105

2.20

28.07

2.0

3.6

ratio

4.4

2.0

0.34

(42529406) Shigella sp [Presence] in Stool by Culture

328

1709

1.96

27.99

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

244

1140

2.18

27.92

2.0

3.6

mg/l

35.6

47.1

0.79

189

915

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

126

430

2.97

27.89

1.2

—

(3022621) pH of Urine by Test strip

539

3276

1.70

27.78

3.6

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

426

2.97

27.74

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

243

1138

2.18

27.65

2.0

3.6

mg/l

47.8

53.5

0.29

186

912

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

163

640

2.58

27.63

1.7

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

139

504

2.79

27.55

1.8

2.2

74.8

73.4

0.58

130

486

(3025468) Yersinia sp identified in Specimen by Organism specific culture

159

620

2.60

27.34

1.7

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

102

311

3.31

27.30

1.6

u/l

4.5

5.0

0.14

155

(3014765) Yersinia sp identified in Stool by Organism specific culture

324

1700

1.95

27.09

1.2

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1622

12508

1.39

27.03

1.9

1.8

mg/l

1.1

1.0

1.08

1232

9291

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

159

624

2.58

26.99

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

159

625

2.58

26.90

1.7

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

321

1688

1.95

26.66

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

203

903

2.29

26.19

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

164

665

2.50

26.02

1.3

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

667

2.49

25.86

1.4

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

134

493

2.75

25.86

1.8

2.2

13.8

13.5

0.08

252

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

903

6312

1.49

25.58

3.1

2.8

umol/l

6.2

7.1

0.86

795

5434

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

262

1302

2.05

25.54

1.3

1.5

u/ml

113.0

111.3

0.04

259

(3014576) Chloride [Moles/volume] in Serum or Plasma

835

5753

1.51

25.35

8.4

7.5

mmol/l

104.5

104.6

0.24

820

5639

(3020961) Endomysium IgA Ab [Titer] in Serum

525

3252

1.66

25.13

1.2

1.1

titre

165.8

179.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

154

620

2.52

24.82

1.4

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

638

4162

1.59

24.75

3.2

2.4

ml/min/173m2

74.5

73.3

0.26

237

1534

(3022217) INR in Platelet poor plasma by Coagulation assay

752

5101

1.53

24.52

13.8

17.4

inr

1.1

1.2

0.89

128

820

(3010503) CD19 cells [#/volume] in Blood

107

359

3.01

24.45

1.8

2.6

e9/l

0.1

0.4

0.97

102

348

(40760888) Immunoglobulin light chains.free panel - Serum

192

860

2.27

24.39

2.1

3.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

904

6379

1.48

24.35

4.9

6.6

mmol/l

1.0

1.34

862

6000

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

611

3964

1.59

24.24

1.3

au/ml

50.5

48.3

0.06

173

(40768441) Liver Pathology biopsy report

118

422

2.83

24.05

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

143

568

2.55

23.73

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

187

839

2.26

23.67

1.4

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

170

735

2.35

23.46

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

258

3.32

22.98

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

447

2.69

22.12

1.8

2.7

e6/l

525.5

524.9

0.00

368

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

140

4.17

21.85

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

134

548

2.47

20.96

2.1

2.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

175

805

2.20

20.89

1.1

g/l

1.4

1.5

0.95

159

726

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

100

357

2.83

20.51

1.3

1.5

u/l

5.6

6.5

0.63

309

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1375

10737

1.35

20.34

2.6

2.9

ng/l

1019.1

927.3

0.31

1185

8895

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

269

3.11

20.20

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1184

9044

1.37

20.16

3.5

3.3

ng/l

351.8

489.7

0.93

781

5992

(3009542) Hematocrit [Volume Fraction] of Blood

5967

56505

1.39

19.94

27.8

12.2

40.1

40.6

4.52

4512

45349

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

735

5180

1.47

19.71

3.0

2.5

u/l

40.1

46.5

0.30

646

4466

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

112

435

2.60

19.53

1.9

2.7

e9/l

0.2

0.16

368

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

154

700

2.23

18.97

1.2

—

(3044889) 12 lead EKG panel

4155

37602

1.26

18.84

3.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

113

451

2.53

18.65

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

402

2515

1.64

18.46

1.1

u/ml

33.5

13.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

3.37

18.40

2.2

3.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

134

584

2.32

18.25

1.3

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

113

456

2.50

18.24

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

119

492

2.44

18.23

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

132

3.88

17.55

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

132

3.88

17.55

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

132

3.88

17.55

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

132

3.88

17.55

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

167

3.49

17.11

1.2

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

187

3.34

17.03

1.7

2.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1988

16653

1.27

17.02

2.5

3.3

mmol/l

2.3

2.4

10.87

1817

14901

(3026389) Candida sp identified in Specimen by Organism specific culture

167

824

2.05

16.72

1.4

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

385

2456

1.60

16.33

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

607

4271

1.46

16.32

1.4

1.3

u/ml

154.9

221.8

1.56

567

3968

(3002032) Base excess in Venous blood by calculation

598

4203

1.46

16.17

4.3

4.5

mmol/l

2.0

1.8

0.79

489

3421

(3021447) Carbon dioxide [Partial pressure] in Venous blood

598

4215

1.46

15.93

4.3

4.4

kpa

5.8

5.9

0.70

580

4091

(3012544) pH of Venous blood

614

4357

1.45

15.78

4.3

4.4

—

7.4

—

(3042631) Mycobacterium sp identified in Specimen

121

540

2.26

15.65

2.7

2.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

250

2.90

15.63

1.2

1.1

u/l

73.9

85.6

0.57

208

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

234

2.97

15.62

1.2

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

123

555

2.24

15.50

1.8

2.4

44.9

44.4

0.05

(3014111) Lactate [Moles/volume] in Serum or Plasma

583

4114

1.46

15.43

7.7

mmol/l

1.3

0.59

561

3968

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

248

2.88

15.26

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

248

2.88

15.26

1.2

1.1

u/l

21.4

21.1

0.01

197

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

122

554

2.22

15.15

1.3

1.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1033

8053

1.33

15.00

3.4

3.8

mmol/l

0.8

0.77

970

7593

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

402

2.43

14.87

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

402

2.43

14.87

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

402

2.43

14.87

1.5

1.7

—

(44790049)

130

611

2.15

14.83

1.4

1.6

—

(44790048)

130

611

2.15

14.83

1.4

1.6

—

(44790047)

130

611

2.15

14.83

1.4

1.6

—

(44806118)

130

611

2.15

14.83

1.4

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

238

2.88

14.58

1.7

2.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4895

45670

1.24

14.57

3.4

—

(3028433) Virus identified in Specimen by Culture

181

3.17

14.46

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

349

2.51

14.31

1.2

1.1

u/ml

12.7

18.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

172

907

1.92

14.31

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

114

516

2.23

14.29

1.4

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

214

2.96

14.26

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

168

3.23

14.17

3.5

4.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

521

7255

0.70

13.92

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

349

2.45

13.34

1.4

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

352

2.43

13.10

2.1

2.7

44.9

42.1

0.51

115

(3016502) Oxygen saturation in Arterial blood

606

4449

1.40

12.83

8.7

8.5

96.3

96.1

0.79

592

4290

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

668

5008

1.37

12.44

8.5

7.9

kpa

5.0

5.1

2.23

648

4803

(3027801) Oxygen [Partial pressure] in Arterial blood

668

5008

1.37

12.44

8.5

7.9

kpa

12.8

13.0

0.35

649

4801

(3009015) Lactate [Moles/volume] in Synovial fluid

5.63

12.40

1.3

1.2

mmol/l

5.0

5.8

0.39

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

263

2.60

12.12

1.6

1.4

u/ml

28.7

21.6

0.41

(3006245) CD3-CD19+ cells/100 cells in Blood

281

2.54

12.08

1.9

2.6

10.0

10.1

0.01

269

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

448

3152

1.45

12.03

2.5

2.8

ng/l

119.7

139.8

0.82

399

2808

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

264

2.59

12.03

1.9

2.3

27.9

28.5

0.13

255

(4034850)

275

1750

1.59

11.85

11.9

8.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

404

2795

1.47

11.84

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

1952

16860

1.22

11.74

2.6

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

497

3594

1.41

11.48

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

567

4195

1.38

11.45

9.4

8.8

g/l

120.5

123.6

2.77

550

4044

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

171

2.94

11.26

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

205

2.75

11.14

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

163

918

1.79

11.11

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

120

616

1.96

10.91

7.8

7.0

mg/l

11.4

11.0

0.46

111

572

(3017704) Immunofixation for Urine

219

2.66

10.88

1.6

1.7

—

(3003396) Base excess in Arterial blood by calculation

656

5009

1.34

10.82

8.6

8.0

mmol/l

0.9

0.01

520

3919

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

344

4934

0.68

10.72

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

169

973

1.76

10.71

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

169

973

1.76

10.71

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

361

2.26

10.65

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

669

5140

1.33

10.58

1.1

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

2.73

10.47

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

2.73

10.47

1.5

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

162

2.91

10.46

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

484

2.06

10.33

2.8

3.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

285

2.40

10.30

1.4

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.65

10.22

1.2

1.6

nmol/l

9.7

532401.2

1.08

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

244

2.51

10.21

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

251

2.48

10.13

1.4

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

164

2730

0.59

10.09

1.4

1.7

mg/l

5.4

3.7

0.63

121

1876

(3027273) Bicarbonate [Moles/volume] in Venous blood

292

1955

1.52

10.09

3.8

3.5

mmol/l

25.5

25.2

0.61

279

1892

(3019060) Gas panel - Arterial blood

391

2774

1.43

10.07

4.9

5.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

909

7339

1.27

9.91

2.2

2.4

29.5

29.6

0.21

876

7134

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1659

14304

1.21

9.85

1.7

1.6

mmol/l

1.5

1.4

0.89

1453

12297

(3021901) Oxygen saturation in Capillary blood

141

793

1.79

9.71

2.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

3.38

9.70

1.7

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

248

1623

1.55

9.53

1.8

2.5

ug/l

274.6

599.6

1.20

221

1513

(3024354) Oxygen [Partial pressure] in Venous blood

469

3470

1.38

9.48

3.8

kpa

4.8

0.00

457

3356

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

114

605

1.90

9.45

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

466

3446

1.38

9.45

3.5

4.2

ng/l

76.1

83.6

0.49

430

3069

(3001964) Herpes simplex virus Ag [Presence] in Specimen

172

2.74

9.41

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

251

2.40

9.17

1.5

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

3.07

9.06

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

375

2693

1.41

9.05

7.4

7.3

mmol/l

24.5

0.09

353

2505

(3006184) Hemoglobin [Mass/volume] in Capillary blood

170

1030

1.67

9.01

2.6

2.2

g/l

132.9

132.4

0.11

122

752

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

280

1912

1.48

8.83

2.1

2.0

—

(3000991) Gas panel - Venous blood

529

4033

1.34

8.82

9.5

9.1

—

(1761868) Lipid panel - Serum or Plasma

2130

23807

0.85

8.81

2.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

452

2.00

8.79

1.9

2.7

e6/l

976.3

759.2

0.82

174

(1616796) Gas panel - Central venous blood

174

1068

1.65

8.78

2.7

3.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

425

2.04

8.78

1.2

1.1

ratio

1.1

0.39

159

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

368

2649

1.41

8.77

1.3

miu/ml

193.0

230.5

1.06

138

1272

(40767503) Oxygen content in Capillary blood by calculation

166

1008

1.66

8.74

2.6

2.5

17.3

16.9

0.69

500

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1023

8510

1.24

8.53

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

680

8486

0.78

8.48

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

255

2.32

8.42

1.5

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

187

1185

1.59

8.32

3.2

3.8

kpa

8.8

0.15

176

1104

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

178

2.59

8.31

1.8

3.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4784

45405

1.17

8.29

3.9

4.0

pmol/l

14.7

14.5

5.97

4473

42135

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

469

1.95

8.28

1.8

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

251

2.32

8.26

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

429

1.99

8.22

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

403

2.02

8.15

3.9

4.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

402

2976

1.37

8.12

3.3

3.7

kpa

5.0

5.2

2.90

381

2787

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.01

8.05

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5541

53286

1.20

8.03

4.4

4.6

mu/l

1.7

2.1

3.81

5219

49976

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

253

1731

1.48

7.94

1.9

1.8

—

(3009343) pH of Capillary blood

396

2939

1.37

7.89

3.3

3.7

7.4

2.53

386

(3000570) Elastase.pancreatic [Mass/mass] in Stool

223

1489

1.51

7.88

1.5

1.4

ug/g

290.9

291.0

0.00

123

836

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

520

1.88

7.88

1.1

mg/l

276.8

284.9

0.48

474

(3044927) Protein electrophoresis panel - Urine

368

2.05

7.85

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

176

1116

1.59

7.83

3.1

3.2

mmol/l

24.3

24.6

0.32

152

983

(3047181) Lactate [Moles/volume] in Blood

217

1446

1.52

7.75

6.0

6.5

mmol/l

1.3

0.06

194

1264

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

165

1034

1.61

7.72

1.3

1.2

u/ml

2.9

3.3

0.19

343

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.53

7.68

1.3

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

229

2.32

7.61

2.0

2.1

ug/l

4.3

3.3

0.39

205

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

242

2.28

7.57

1.5

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

193

2.44

7.55

2.4

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

382

2843

1.36

7.49

3.3

3.6

mmol/l

1.6

1.5

0.05

271

2114

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

103

3.02

7.44

1.2

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

531

4153

1.30

7.40

6.4

8.6

mmol/l

8.1

8.3

0.48

507

4004

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

159

1001

1.60

7.32

1.1

—

(3051651) Icteric interference index of Serum or Plasma

331

2.06

7.30

2.7

3.5

—

(3029075) Extractable nuclear Ab panel - Serum

178

2.48

7.30

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

246

1706

1.46

7.24

6.1

5.7

1.7

0.25

238

1586

(3046861) Legionella sp Ag [Presence] in Urine

6.88

7.14

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

242

2.24

7.14

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

242

2.24

7.14

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

242

2.24

7.14

1.5

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

332

2436

1.38

7.12

11.1

10.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1467

12832

1.18

7.11

2.5

2.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

930

0.43

7.08

4.0

5.5

umol/l

347.3

373.0

0.82

818

(3003338) MCHC [Mass/volume]

5489

52891

1.18

7.07

34.4

14.3

g/l

331.6

333.4

39.73

5475

52537

(3020393) Adenovirus Ag [Presence] in Stool

3.39

6.96

1.5

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

535

1.81

6.94

1.1

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.56

6.85

1.0

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

328

2.02

6.74

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.45

6.70

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.01

6.70

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

387

1.92

6.55

3.0

2.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.96

6.52

1.3

1.5

—

(3025577) Chromium [Mass/volume] in Blood

226

2.22

6.52

2.1

ug/l

2.5

2.6

0.10

194

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

246

2.16

6.48

1.2

1.3

—

659.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

976

8298

1.20

6.47

2.1

2.9

mmol/l

2.4

0.90

855

7268

(3019420) Tryptase [Mass/volume] in Serum or Plasma

355

1.95

6.41

1.3

1.4

ug/l

5.8

7.2

1.05

312

(1761482) Bacteria [#/volume] in Urine by Culture

147

940

1.58

6.39

5.0

3.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

277

2010

1.39

6.39

3.3

0.7

0.84

260

1925

(3007930) Methemoglobin/Hemoglobin.total in Blood

239

1690

1.43

6.39

6.2

5.9

0.9

0.28

231

1574

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

326

2447

1.35

6.11

4.7

5.0

mmol/l

24.3

24.1

0.85

291

2216

(3036048) Francisella tularensis Ab [Titer] in Serum

157

2.43

6.09

1.1

—

204.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

217

1524

1.44

6.04

3.2

3.8

u/ml

2679.0

1277.0

0.25

184

1313

(3049717) Cytology report of Urine Cyto stain

194

1334

1.47

6.03

2.3

2.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

1.98

6.00

1.1

—

(3016135) IgD [Mass/volume] in Serum

6.26

5.95

1.2

mg/l

49.1

76.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.98

5.94

1.4

1.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

223

1582

1.42

5.89

3.2

5.0

mg/l

1.3

1.4

0.85

211

1501

(3004119) Hemoglobin [Mass/volume] in Venous blood

348

2655

1.33

5.85

3.8

3.6

g/l

129.8

131.7

0.85

337

2596

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.54

5.59

1.2

1.1

—

(3020891) Body temperature

245

1786

1.39

5.55

5.0

4.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

151

1007

1.51

5.50

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

2.90

5.45

2.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.90

5.45

1.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

276

2060

1.35

5.41

3.3

3.4

1.4

1.3

0.23

276

2045

(3037121) Protein [Mass/volume] in Urine

236

1720

1.39

5.37

2.8

3.5

g/l

0.2

0.4

1.54

111

807

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

350

1.87

5.34

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

150

1006

1.50

5.33

1.3

1.2

u/ml

5.0

4.4

0.21

445

(3015183) Erythrocyte sedimentation rate

395

1.81

5.27

1.3

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

381

1.82

5.25

1.7

2.2

—

(3019225) pH of Specimen

553

4540

1.24

5.20

3.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

256

2.00

5.16

1.3

1.6

u/field

2.2

3.5

0.64

192

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

465

1.73

5.13

1.5

umol/l

11.7

11.5

0.12

445

(3012501) Base excess in Blood by calculation

162

1115

1.46

5.08

2.8

4.0

mmol/l

2.2

2.3

0.14

109

737

(3013512) EKG study

1490

13363

1.15

5.02

3.4

3.2

—

(3000060) B lymphocytes [#/volume] in Blood

218

2.07

5.01

1.8

2.5

e6/l

207.5

182.4

0.15

124

(3010421) pH of Blood

185

1311

1.42

4.98

2.9

4.0

7.4

1.86

161

1098

(3024891) Influenza virus A+B Ag [Presence] in Specimen

235

1740

1.36

4.88

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

145

988

1.48

4.81

1.4

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

164

2309

0.70

4.75

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

164

2307

0.70

4.72

1.4

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

132

2.35

4.72

1.3

1.8

u/l

17.3

44.9

1.16

121

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

307

2378

1.30

4.70

2.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

164

2298

0.71

4.63

1.4

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

300

0.30

4.59

2.3

nmol/l

124.8

151.3

—

255

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

165

2303

0.71

4.55

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

181

2.11

4.46

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

610

7199

0.83

4.44

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

142

983

1.45

4.38

2.0

3.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

352

4389

0.79

4.37

1.4

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

3.34

4.32

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

184

2489

0.73

4.21

1.4

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

395

1.70

4.16

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

109

2.39

4.13

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

426

3496

1.23

4.07

2.1

2.2

ug/l

5.9

7.7

1.47

372

3131

(3001019) Free T4 and TSH panel - Serum or Plasma

346

4280

0.80

4.03

1.6

1.7

—

(3002256) Pathology report gross observation

788

6855

1.17

3.99

1.3

1.2

—

(3039000) Anion gap in Blood

141

994

1.43

3.98

7.5

8.0

mmol/l

11.0

11.3

0.63

134

888

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

104

691

1.51

3.97

1.5

1.4

pmol/l

296.8

352.1

0.42

541

(3018572) Chloride [Moles/volume] in Blood

141

995

1.43

3.96

7.5

8.0

mmol/l

105.1

105.2

0.17

134

889

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

190

2.01

3.96

1.7

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

190

2.01

3.96

1.0

1.1

—

(4268621)

107

717

1.50

3.93

2.4

2.3

—

(3050794) Legionella sp Ab [Presence] in Serum

3.13

3.92

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.64

3.92

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

638

1.53

3.89

1.9

90.6

90.4

0.23

630

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

505

5979

0.83

3.82

3.6

3.9

32.6

31.5

1.41

415

4327

(3018405) Lactate [Moles/volume] in Arterial blood

203

1533

1.33

3.79

3.8

3.9

mmol/l

1.3

1.4

0.17

197

1510

(3011985) Renin [Units/volume] in Plasma

108

732

1.48

3.77

1.6

mu/l

59.3

56.7

0.05

101

660

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.00

3.69

1.1

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

472

1.60

3.66

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

176

1311

1.35

3.62

4.0

4.2

mmol/l

3.8

3.9

1.02

168

1237

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

190

1.95

3.61

1.7

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

190

1.95

3.61

1.7

2.2

—

(3036489) Thrombin time

278

2206

1.27

3.61

2.6

2.3

21.3

0.01

235

1895

(3010375) cycloSPORINE [Mass/volume] in Blood

306

1.74

3.59

14.8

26.7

ug/l

120.9

118.6

0.06

248

(4306422)

143

1032

1.39

3.58

1.2

—

(3048879) Bone marrow aspiration report

2.35

3.56

1.3

2.3

—

(40768793) Breast Pathology biopsy report

1264

0.66

3.56

1.2

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

460

1.59

3.56

1.4

1.3

nmol/l

1.6

1.4

0.78

417

(3047352) Trisomy 18 risk [Likelihood] in Fetus

135

1862

0.72

3.55

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

427

0.42

3.55

1.3

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

10.01

3.49

1.0

—

(3005033) Fetal Nuchal fold Thickness US

135

1855

0.72

3.48

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

228

2904

0.78

3.45

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

464

1.58

3.44

1.2

1.3

u/ml

0.1

0.8

1.84

180

(1617658) Protocol used for examination of sentinel lymph nodes

419

0.43

3.40

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

248

1957

1.28

3.39

2.7

94.0

93.7

0.07

232

1816

(3043238) Trisomy 21 risk [Likelihood] in Fetus

141

1915

0.73

3.38

1.4

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.44

3.33

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

218

1.84

3.30

2.6

2.7

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

226

1770

1.29

3.29

3.0

2.8

181.8

178.8

0.20

217

1694

(3039443) Prostate specific Ag panel - Serum or Plasma

1134

0.66

3.28

1.6

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

510

1.54

3.27

3.0

2.1

mg/l

30.7

25.3

0.36

138

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

237

1869

1.28

3.27

1.1

u/ml

3.1

6.4

1.05

288

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

293

2370

1.25

3.27

11.9

10.3

mmol/l

24.2

0.03

277

2240

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

223

1747

1.29

3.25

3.4

3.0

g/l

3.6

3.5

0.18

209

1665

(3022493) Free Hemoglobin [Mass/volume] in Plasma

220

1.82

3.22

1.4

6.9

mg/l

3382.1

68.4

0.49

161

(3052592) Norovirus Ag [Presence] in Stool

2.44

3.21

1.7

1.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

9.5

5.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

0.8

0.9

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

2.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

0.6

1.9

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

3.1

2.4

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

0.8

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

0.7

1.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.73

3.15

1.4

1.6

mg/l

1.6

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

2.22

3.15

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

174

1325

1.32

3.14

3.7

3.9

u/ml

0.3

0.70

735

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

476

1.54

3.12

1.1

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5844

57318

1.12

3.11

4.1

3.9

mmol/l

4.7

4.8

3.96

5599

54367

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

246

1964

1.26

3.09

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

135

992

1.37

3.08

1.1

128.3

116.6

3.57

122

913

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

518

1.51

3.07

1.2

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

209

1.82

3.07

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

209

1.82

3.07

1.3

1.7

—

(4198724)

455

0.48

3.07

2.2

2.9

—

(3003181) Sodium [Moles/volume] in Urine

102

717

1.43

3.02

2.0

1.4

mmol/l

70.7

64.5

0.60

570

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

513

1.51

2.99

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

140

1043

1.35

2.95

1.1

—

(3020650) Glucose [Presence] in Urine

169

1.90

2.94

1.6

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

126

1696

0.74

2.90

2.3

3.0

—

(4035726)

505

4356

1.17

2.90

1.3

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.43

2.87

1.1

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

229

1.75

2.86

1.4

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

157

1.91

2.84

1.0

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.40

2.79

2.2

umol/l

1.2

1.3

0.57

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

4.45

2.79

1.1

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.64

2.79

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.55

2.78

1.4

1.6

mg/l

0.2

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.86

2.74

1.2

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1041

0.68

2.73

1.3

1.2

—

(3000012) Reticulocyte production index

218

1.75

2.71

1.4

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

423

1.52

2.63

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1435

13300

1.10

2.61

3.2

3.3

mg/l

796.4

410.0

1.39

933

8509

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.00

2.56

1.5

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

200

1.75

2.55

1.2

99.2

92.0

0.54

(4281824)

550

0.58

2.50

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

332

1.57

2.50

1.4

1.9

u/field

1.9

1.7

0.08

160

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

209

1.73

2.49

1.2

1.1

101.6

92.0

1.18

(3030313) Adrenal Ab [Titer] in Serum

2.32

2.48

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

484

0.56

2.46

7.2

12.1

mmol/l

0.6

0.37

447

(3020682) Albumin/Creatinine [Ratio] in Urine

1494

13913

1.09

2.44

3.9

4.1

mg/mmol

9.8

10.7

0.21

977

9005

(3013293) Extractable nuclear Ab [Presence] in Serum

2.09

2.42

1.5

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5189

50762

1.09

2.42

4.7

4.8

mmol/mol

37.7

38.6

10.89

4944

47944

(3001218) Citrate [Mass/time] in 24 hour Urine

6.25

2.37

2.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1174

10832

1.10

2.34

2.1

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

168

1334

1.27

2.30

1.6

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

462

1.45

2.28

2.8

2.9

mg/l

40.5

69.4

0.63

329

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

234

1930

1.22

2.28

3.4

3.8

mmol/l

24.6

24.7

0.31

221

1820

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1066

9805

1.10

2.27

2.0

2.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.56

2.26

1.4

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

223

1832

1.22

2.26

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

314

0.48

2.25

2.4

6.8

u/ml

—

9022.9

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

156

1.80

2.25

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

498

1.43

2.22

3.4

5.9

mmol/l

7.2

7.1

0.09

414

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.88

2.20

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

107

807

1.33

2.17

1.2

1.3

nmol/l

0.2

0.3

—

(3009508) Creatinine [Moles/volume] in Urine

1663

15637

1.08

2.16

3.0

3.3

mmol/l

8.1

0.14

1444

13497

(3045683) HLA typing for celiac disease panel - Blood or Tissue

435

1.45

2.15

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

242

1.62

2.15

1.4

1.2

g/l

0.3

0.85

193

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.29

2.15

1.2

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

3.69

2.15

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.16

2.14

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

144

1.81

2.14

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5792

57019

1.09

2.12

4.0

3.9

mmol/l

1.5

13.25

5536

53901

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

114

873

1.31

2.09

3.4

3.7

u/ml

252.6

600.5

0.52

802

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

221

1.63

2.08

1.4

1.2

109.4

109.9

0.05

195

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

670

7409

0.89

2.05

2.4

2.5

ug/l

0.6

0.7

0.85

387

4164

(3025130) Human papilloma virus identified in Specimen

126

982

1.29

2.04

1.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

288

0.49

2.03

7.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

288

0.49

2.03

3.5

3.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.40

2.02

1.0

—

3.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

408

1.45

2.02

2.7

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

343

3952

0.86

1.99

1.7

2.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

190

1560

1.22

1.98

1.3

1.4

mg/l

685.1

495.9

0.44

175

1488

(40762814) Titanium [Mass/volume] in Blood

2.28

1.97

2.5

2.2

ug/l

4.7

4.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

288

1.53

1.97

1.1

1.2

—

(44806071)

1.98

1.94

1.1

1.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5872

57891

1.09

1.93

4.4

4.2

mmol/l

2.8

2.9

13.50

5601

54555

(3002619) Bacteria identified in Specimen by Culture

120

1.84

1.92

1.5

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1855

17592

1.07

1.91

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

422

1.43

1.90

2.7

2.3

mmol/l

3.9

4.0

0.95

415

(3035285) Chloride [Moles/volume] in Venous blood

422

1.43

1.90

2.7

2.3

mmol/l

106.0

105.6

0.37

415

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.18

1.88

1.0

—

(21494434) Karyotype in Bone marrow

357

1.46

1.87

1.1

1.2

—

(44813793)

483

1.39

1.85

1.1

—

(3028300) Cannabinoids [Presence] in Urine

348

3981

0.87

1.85

1.7

2.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

569

1.36

1.84

1.4

mmol/l

12.7

11.6

0.56

126

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.53

1.83

1.0

3.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

168

1376

1.23

1.82

1.2

1.3

mmol/l

3.5

3.7

1.53

151

1293

(3047189) Immunofixation for 24 hour Urine

183

1.64

1.81

1.6

1.8

—

(3027008) Opiates [Presence] in Urine

348

3974

0.87

1.81

1.7

2.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.57

1.80

2.1

4.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.74

1.79

1.1

1.2

105.0

106.4

0.07

129

(3045716) Anion gap in Serum or Plasma

192

1.62

1.77

6.5

2.6

mmol/l

8.5

9.5

0.95

140

(40768800) Prostate Pathology biopsy report

630

0.68

1.76

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.44

1.75

1.3

1.1

—

(40757373) Influenza virus identified in Isolate

1.93

1.74

1.4

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

330

1.46

1.73

1.4

mmol/l

5.7

6.2

0.42

304

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

168

1384

1.22

1.73

1.3

1.5

e6/l

5810.9

4106.9

0.14

135

1114

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

168

1384

1.22

1.73

1.3

1.5

e6/l

46.5

25.8

0.44

127

1050

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

490

1.37

1.72

1.1

1.3

mmol/l

2.5

2.0

0.60

458

(3027944) Amphetamines [Presence] in Urine

343

3905

0.87

1.72

1.8

2.1

—

(3016879) Cocaine [Presence] in Urine

321

3670

0.87

1.71

1.8

2.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.13

1.71

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.06

1.70

1.0

—

(3022313) Gas panel - Capillary blood

252

2161

1.17

1.68

3.3

3.7

—

(3017569) Oxygen content in Arterial blood

187

1.61

1.68

1.6

2.5

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1160

0.77

1.66

1.2

1.3

ug/l

2.8

4.0

1.65

1058

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1146

0.77

1.64

1.0

1.1

u/ml

3.0

5.9

1.37

471

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

141

1721

0.82

1.63

1.1

u/ml

0.5

1.9

5.11

715

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

556

1.33

1.62

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

486

0.66

1.60

1.5

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

238

1.52

1.59

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

159

1.64

1.58

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

136

1.69

1.58

1.1

68.5

67.1

—

(3016038) Potassium [Moles/volume] in Urine

288

1.46

1.56

2.1

1.3

mmol/l

36.7

35.3

0.08

258

(3012441) Differential panel - Pleural fluid

330

1.43

1.55

1.5

—

(4146454)

446

0.65

1.55

2.8

2.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

657

1.30

1.54

1.2

1.3

nmol/l

19.2

36.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.03

1.54

1.2

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

399

1.38

1.52

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

2.59

1.51

1.3

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.67

1.51

1.1

74.9

79.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

332

1.42

1.51

1.1

1.2

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

572

1.31

1.50

1.1

mg/l

219.6

254.2

1.13

508

(3042111) Morphology [Interpretation] in Bone marrow Narrative

696

1.28

1.49

1.6

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.90

1.49

2.2

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

267

3055

0.87

1.48

1.8

2.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1188

11191

1.07

1.47

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

393

3517

1.12

1.46

2.3

2.4

u/l

7128.5

5708.5

0.25

128

1378

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

129

1056

1.23

1.46

1.1

u/ml

1.9

3.6

2.54

562

(4010399)

414

3721

1.12

1.44

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

379

1.37

1.41

1.5

e6/l

8447.4

2264.6

1.25

266

(3010726) Horse dander IgE Ab [Units/volume] in Serum

120

1461

0.82

1.40

1.0

1.1

u/ml

2.6

2.4

0.04

363

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

588

1.30

1.40

1.2

1.1

mg/l

39.0

39.8

0.05

495

(40765089) Chromosome analysis panel - Blood by G-banded

299

0.60

1.36

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

382

1.36

1.5

1.9

mg/l

2.7

3.8

2.95

372

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

124

0.40

1.36

1.0

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

168

1424

1.18

1.35

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method

231

2647

0.87

1.33

2.0

3.3

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

1.33

0.0

1.4

—

28.4

—

(3045788) Cell count panel - Pleural fluid

307

1.40

1.33

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

136

1626

0.83

1.33

1.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

128

1.64

1.33

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

321

0.62

1.32

39.9

35.6

ug/l

7.3

7.4

0.20

298

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.97

1.32

1.3

3.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

271

0.59

1.31

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

385

1.35

1.31

1.2

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

101

1238

0.81

1.28

1.0

1.1

u/ml

3.7

4.3

0.13

492

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

1.27

1.2

1.3

—

(3012565) Volume of 24 hour Urine

277

1.41

1.26

1.3

2.3

2308.7

2011.9

0.88

257

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.82

1.25

1.1

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.40

1.24

1.0

1.1

—

(3004451) EKG impression Narrative

195

1.49

1.23

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

163

1.54

1.22

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1020

0.80

1.21

1.0

1.1

u/ml

0.0

0.5

2.43

223

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

593

0.74

1.20

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

148

1.56

1.19

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

694

1.24

1.17

1.3

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

819

8723

0.93

1.17

1.6

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

578

0.74

1.16

1.2

1.6

promille

1.0

1.4

0.93

441

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.81

1.15

2.5

2.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

126

1490

0.84

1.13

1.1

u/ml

0.6

1.2

1.04

654

(3044009) aPTT.lupus sensitive (LA screen)

1.85

1.13

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

437

0.71

1.13

1.6

2.2

ug/l

15.4

23.9

1.40

428

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5567

55043

1.06

1.10

3.8

3.5

mmol/l

1.3

0.74

5314

51846

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

201

1.44

1.09

1.2

33.6

15.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

104

1.64

1.09

1.2

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.73

1.08

1.1

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.95

1.08

1.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

363

0.69

1.08

1.2

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.19

1.08

1.3

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.19

1.08

1.7

5.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

948

10013

0.94

1.07

3.1

3.4

22.1

21.4

0.62

363

3896

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

287

1.36

1.06

1.2

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

313

1.34

1.06

1.1

90.1

94.9

0.68

255

(3044290) Cell count panel - Cerebral spinal fluid

150

1292

1.16

1.05

1.3

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.12

1.05

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

138

1.52

1.02

3.0

2.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

734

1.22

1.02

1.1

—

16.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

1.02

1.8

2.5

u/field

0.4

0.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

133

1548

0.86

1.01

1.1

u/ml

3.1

6.3

2.51

830

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

727

1.21

1.00

1.2

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

334

1.32

0.99

1.6

1.5

e6/l

51122.5

84998.1

0.47

193

(3033923) Metanephrine [Moles/time] in 24 hour Urine

107

1.59

0.99

1.2

1.1

umol/24h

0.8

0.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

278

2510

1.11

0.97

1.6

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

479

0.75

0.95

1.2

1.4

nmol/l

31.1

31.5

0.03

423

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

614

0.78

0.95

1.3

pmol/l

63.1

116.0

0.51

188

(4027681)

462

1.26

0.93

1.3

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

172

0.58

0.93

1.4

2.2

umol/l

16.7

16.1

—

172

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

349

1.29

0.90

1.5

—

(3017509) Phencyclidine [Presence] in Urine

102

0.49

0.89

1.0

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1002

0.84

0.88

1.5

1.6

—

(4094501)

166

1464

1.14

0.88

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

111

1.53

0.87

1.8

2.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

482

0.77

0.86

1.1

1.0

u/ml

0.2

2.0

—

(3006462) Nitrate [Presence] in Urine

229

1.36

0.86

3.2

2.7

—

(3022689) Creatine [Moles/volume] in Urine

161

1.43

0.86

1.5

—

(3035880) pH of Pleural fluid

161

1.43

0.86

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

123

1065

1.16

0.85

2.2

2.3

umol/l

5.6

6.1

0.23

780

(3014599) Egg white IgE Ab [Units/volume] in Serum

522

0.78

0.81

1.0

1.1

u/ml

0.5

3.1

1.44

134

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.82

0.79

1.3

1.8

—

(40758358) Immune stain study

0.00

0.79

0.0

1.0

—

(3036603) Volume of Urine

339

1.27

0.78

1.8

1.5

2059.7

2046.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.59

0.78

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

880

9213

0.95

0.77

1.6

1.8

1.5

1.4

1.66

770

8279

(40761539) Cells [Type] in Urine sediment by Light microscopy

123

1.46

0.77

1.1

—

(3034426) Prothrombin time (PT)

243

1.32

0.76

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

187

2078

0.90

0.76

1.5

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

430

1.23

0.76

1.1

iu/ml

17.4

9.4

0.40

119

(4211845)

252

1.31

0.76

3.1

2.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

1165

0.86

0.74

1.7

2.4

nmol/l

1.0

0.8

1.85

987

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.74

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.67

0.74

3.8

6.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

508

4784

1.07

0.72

1.2

iu/ml

96.2

153.0

3.14

191

1829

(3003740) Influenza virus B Ag [Presence] in Specimen

151

1346

1.12

0.72

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

151

1347

1.12

0.71

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.92

0.70

1.4

1.2

—

(3051339) Copper [Moles/volume] in Blood

1.71

0.70

1.3

1.2

umol/l

14.9

16.7

—

(3000285) Sodium [Moles/volume] in Blood

1.55

0.69

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

197

1788

1.10

0.69

1.6

1.4

—

(40768795) Lymph node Pathology biopsy report

509

0.80

0.69

1.1

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.53

0.68

1.0

1.2

u/ml

0.3

0.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.67

0.68

1.0

1.1

—

5.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

375

0.77

0.68

1.8

1.5

—

(40758292) HTLV I+II Ab panel - Serum

118

0.59

0.67

1.3

1.4

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.53

0.66

1.0

u/ml

2.1

2.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

402

1.22

0.66

1.1

u/l

1.1

0.02

182

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.79

0.66

1.0

1.4

u/l

16.0

2961.7

—

(3006653) Thiamine [Moles/volume] in Blood

294

1.26

0.66

1.3

1.4

nmol/l

132.6

135.0

0.17

294

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

669

0.84

0.65

1.9

1.6

mmol/l

7.6

0.02

412

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

423

3976

1.07

0.65

2.9

3.4

pmol/l

4.5

0.40

392

3574

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

483

0.81

0.65

1.8

2.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

783

1.15

0.64

1.2

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.72

0.64

1.2

32.2

36.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

382

0.78

0.63

1.7

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

672

1.16

0.63

1.1

—

(3000492) Spirometry study

654

6240

1.05

0.62

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

433

1.20

0.62

1.6

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

244

1.27

0.61

1.1

ng/l

310.6

376.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1121

0.88

0.60

1.4

1.5

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

115

0.61

0.57

11.0

7.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

116

0.60

0.57

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.67

0.56

1.0

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

475

1.18

0.56

2.9

3.0

nmol/l

0.9

0.8

0.41

356

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

115

1.39

0.56

1.2

1.7

ug/l

3.9

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

282

3019

0.93

0.56

2.2

3.2

u/ml

38.8

46.3

0.43

271

2914

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.56

0.55

4.2

7.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

533

1.16

0.54

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

108

1.39

0.53

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

657

1.14

0.52

1.5

1.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.39

0.50

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

839

1.12

0.50

2.3

2.5

—

(3019174) dRVVT (LA screen)

1.49

0.49

1.3

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

614

5896

1.05

0.48

6.5

5.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

258

2750

0.94

0.48

1.8

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

300

1.20

0.46

1.6

nmol/l

3.6

4.8

0.22

237

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.43

0.46

1.1

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

228

1.23

0.45

1.0

1.1

u/ml

0.1

6.4

1.09

133

(3023183) Ammonium ion [Moles/volume] in Plasma

117

1066

1.10

0.44

3.5

3.2

umol/l

33.1

35.9

0.76

102

940

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

127

0.71

0.43

1.7

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

0.70

0.43

2.8

5.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

987

0.90

0.43

1.5

1.4

mmol/l

6.8

7.0

0.34

722

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.64

0.42

2.7

3.1

u/l

581.5

2903.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.63

0.42

1.0

u/ml

0.6

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.38

0.41

1.4

1.2

umol/24h

1.4

1.6

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

450

4314

1.05

0.41

3.1

4.2

ug/l

86.3

28.4

0.73

341

3363

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

143

1545

0.92

0.40

1.5

2.0

iu/l

3.7

4.5

0.60

604

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.40

0.0

7.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

6.5

—

0.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.39

0.40

21.7

8.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

221

2349

0.94

0.40

1.9

1.8

—

(4212803)

1.47

0.40

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

113

1035

1.09

0.40

1.1

iu/ml

53.3

9842.4

0.64

274

(3013139) Helicobacter pylori Ag [Presence] in Stool

368

3853

0.95

0.40

1.2

—

(3001556) Androgen free Index in Serum or Plasma

102

0.69

0.39

1.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

102

0.69

0.39

6.1

2.5

mmol/l

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

106

1158

0.91

0.39

1.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

14.2

—

(3019977) pH of Arterial blood

242

1.20

0.38

3.3

3.2

7.4

0.38

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

163

1520

1.07

0.38

1.7

1.9

pmol/l

199.2

203.2

0.20

154

1442

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

159

0.75

0.38

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.39

0.38

1.0

1.9

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.34

0.38

1.0

—

(40768806) Pleura Pathology biopsy report

336

1.16

0.37

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.39

0.36

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.39

0.36

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.33

0.35

1.8

1.9

pmol/l

50.7

41.1

0.24

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

118

1275

0.92

0.35

1.4

1.5

nmol/l

0.3

0.4

1.70

1003

(3037556) Urate [Mass/volume] in Serum or Plasma

134

0.75

0.34

1.1

1.3

—

(3024928) Oxygen saturation in Venous blood

111

1025

1.08

0.34

3.3

4.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

247

2346

1.05

0.34

1.5

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.33

0.33

1.7

2.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.70

0.33

1.0

1.3

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

229

1.18

0.32

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

292

3050

0.96

0.31

1.5

1.6

mu/l

277.3

304.9

0.79

260

2745

(3042733) HLA Ab [Presence] in Serum

241

0.83

0.31

3.5

5.1

—

(3008295) Osmolality of Serum or Plasma

522

1.11

0.31

1.8

1.5

mosm/kgh2o

277.9

282.4

0.93

415

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

147

1.23

0.30

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

147

1.23

0.30

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

147

1.23

0.30

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

604

6210

0.97

0.29

2.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.25

0.29

1.1

1.3

—

577.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

103

1106

0.93

0.29

2.3

2.5

ug/min

89.8

132.9

0.61

715

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

480

0.90

0.27

1.3

1.9

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

121

0.74

0.27

1.2

1.5

49.7

56.1

—

101

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.26

0.26

2.3

3.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

234

2440

0.96

0.25

1.3

1.5

u/l

9.4

9.2

0.06

199

1989

(40765096) Chromosome analysis panel by Banding

142

1.20

0.24

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.17

0.24

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.71

0.24

1.3

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

181

1892

0.96

0.23

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

294

1.12

0.23

1.5

2.5

umol/l

159.4

158.2

0.00

150

(3004775) Volume in Urine collected for unspecified duration

369

0.89

0.22

1.6

2.4

911.0

636.8

1.91

271

(3014891) Appearance of Pleural fluid

1.25

0.22

1.0

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.22

1.0

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

448

1.09

0.22

2.4

2.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

229

1.14

0.21

1.2

1.1

—

(3016750) Collection duration of Urine

294

0.88

0.21

1.8

2.3

min

526.5

491.6

0.87

232

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.19

0.21

1.2

1.5

umol/24h

406.0

338.6

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.5

—

1353.4

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

135

1.19

0.21

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

230

1.13

0.20

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

123

0.81

0.20

8.6

6.9

—

(3025315) Body weight

1.25

0.20

3.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.20

0.19

1.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.18

0.19

1.3

1.1

—

(4015189)

1.22

0.19

3.2

2.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

203

1.13

0.19

1.8

2.3

—

(1002224) Polysomnography panel

323

3144

1.03

0.18

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

119

1.18

0.17

1.1

ug/l

73.9

78.7

—

103

(3051387) C reactive protein [Mass/volume] in Capillary blood

103

1080

0.95

0.17

4.2

3.2

mg/l

23.4

24.2

0.09

649

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

131

0.84

0.17

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.75

0.17

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

631

1.06

0.16

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

120

1.17

0.16

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

172

0.87

0.15

2.2

e6/l

505.6

721.3

—

127

(44806420)

0.77

0.15

2.5

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.77

0.15

1.3

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

242

2356

1.03

0.15

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

387

3950

0.98

0.15

1.4

iu/l

23.9

25.9

0.67

344

3365

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

169

1.12

0.14

1.4

1.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

512

0.94

0.14

1.0

1.1

u/ml

0.4

1.9

1.25

152

(3001893) Eosinophils/100 leukocytes in Pleural fluid

100

0.80

0.13

1.3

1.5

2.8

3.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

109

0.83

0.13

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

376

0.93

0.13

4.9

6.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

210

0.90

0.12

1.2

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

374

3676

1.02

0.12

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

289

1.07

0.11

2.0

1.8

—

(3003129) Base excess in Capillary blood by calculation

1.15

0.10

1.1

1.6

mmol/l

-0.2

0.6

0.44

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

187

0.91

0.10

2.6

2.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

111

1077

1.03

0.10

4.1

2.4

13.4

13.1

2.13

111

1063

(3029396) Erythrocyte agglutination [Presence] in Blood

228

0.92

0.10

2.6

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5437

54463

0.99

0.09

3.6

3.9

mmol/l

5.7

5.8

6.18

5106

50847

(3022475) Manganese [Moles/volume] in Blood

1.06

0.09

1.8

1.3

—

(3033799) Differential panel - Peritoneal fluid

144

0.90

0.08

1.9

2.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

166

1.08

0.07

1.1

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.80

0.07

1.7

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.84

0.07

1.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

132

1293

1.02

0.07

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.07

0.07

1.1

1.6

ng/l

93.2

107.9

—

(3045142) Bone marrow Pathology biopsy report

509

0.96

0.07

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

157

1.08

0.07

1.5

1.6

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.85

0.06

1.3

1.5

25.0

29.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

152

0.92

0.06

1.7

2.0

e6/l

122.8

17235.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

276

1.05

0.06

1.1

1.8

—

6.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

119

1.09

0.06

1.5

g/l

10.6

12.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

139

1.08

0.05

1.3

1.6

—

(4024509)

445

0.97

0.05

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

0.95

0.05

1.0

—

(3011648) Oxygen content in Venous blood

426

1.03

0.05

3.0

3.7

11.2

11.3

0.03

426

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

130

1.08

0.04

1.5

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

489

4920

0.99

0.04

1.8

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4230

42250

1.00

0.04

3.8

3.0

u/l

52.4

43.1

7.40

4042

40225

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

358

1.03

0.04

1.2

1.1

nmol/l

10.2

5.5

—

(40768446) Kidney Pathology biopsy report

269

1.04

0.04

1.4

1.7

—

(3035637) Corticotropin [Mass/volume] in Plasma

773

0.98

0.03

1.4

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

464

4663

0.99

0.03

2.0

2.2

nmol/l

13.2

13.0

0.24

423

4203

(3024471) HLA-A [Type]

231

1.04

0.02

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.06

0.02

5.0

3.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

142

1.06

0.02

5.0

3.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

560

1.02

0.02

1.9

3.1

nmol/l

4.3

14.7

0.53

543

(3020491) Glucose [Moles/volume] in Blood

421

1.02

0.02

2.2

1.7

mmol/l

7.0

6.3

1.07

306

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1260

12616

1.00

0.01

3.5

3.8

ug/l

1.6

2.0

3.06

1160

11537

(3024932) HLA-DR beta [Type]

227

0.97

0.01

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.06

0.01

1.1

1.5

—

140.4

—

(3042517) Benzodiazepines panel - Urine

106

0.94

0.01

2.3

2.6

—

(4133840)

194

1.03

0.00

1.0

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.03

0.00

1.4

1.3

mmol/l

4.4

3.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

147

1.02

0.00

1.1

—

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

146

1.03

0.00

6.4

8.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

266

1.02

0.00

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

306

1.01

0.00

1.5

1.7

nmol/l

1.2

1.3

0.27

238

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

121

1207

1.00

0.00

1.3

1.4

u/l

24.6

23.9

0.09

106

999

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

135

0.96

0.00

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

275

1.02

0.00

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

632

1.00

0.00

3.3

4.7

u/ml

41.2

67.9

0.64

187

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

46.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1482.5

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

12.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.90

0.00

3.5

3.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

170.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.94

0.00

1.2

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

43.4

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

140

1.00

0.00

1.8

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.02

0.00

1.7

1.8

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

3.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.0

—

11.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_RHEUMA_BIOLOGICAL and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_RHEUMA_BIOLOGICAL	1.215 [1.03, 1.43]	0.02
Birth year	0.995 [0.99, 1.0]	0.23

During the follow-up period (1.1.1998 — 31.12.2019), 412 out of 12676 females with RX_RHEUMA_BIOLOGICAL died.

Males

Parameter	HR [95% CI]	p-value
RX_RHEUMA_BIOLOGICAL	1.05 [0.89, 1.24]	0.563
Birth year	0.989 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 404 out of 9858 males with RX_RHEUMA_BIOLOGICAL died.

Mortality risk

Mortality risk for people of age

years, who have RX_RHEUMA_BIOLOGICAL.

N-year risk	Females	Males
1	0.084%	0.15%
5	0.616%	1.265%
10	1.714%	3.156%
15	3.288%	6.052%
20	6.051%	10.247%

Relationships between endpoints

↥

Index endpoint: RX_RHEUMA_BIOLOGICAL – Biological medication for rheuma

GWS hits: 10

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Biological medication for rheuma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints